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Introduction 
Groundwater is a primary source of drinking 
water for about 50 percent of the population in the 
U.S. This source of drinking water has been gen-
erally regarded as safe from contamination. Several 
papers indicate that nwnerous underground storage 
tanks containing petroleum products may be leak-
ing and contaminating public water supply wells 
across the U.S.(Matis, 1971; Ferguson, 1979; 
Woodhull, 1981; Bunnaster and Harris, 1982; 
Lehman, 1984; Dowd, 1984; OTA, 1984). A 
study conducted by the Utah Bureau of Solid and 
Hazardous Wastes in 1985 concluded that there are 
at least 2,314 underground steel tanks, most of 
which are used to store gasoline and diesel fuel, in 
Utah which are more than 20 years old and may be 
leaking. 
Contamination of well water by petroleum 
products from Jeakingunderground storage tanks 
(LUST) is a matter of increasing concern. LUST 
pose a serious threat to the groundwater and public 
health. Leaks of petroleum products from LUST 
at industrial plants, commercial establishments 
(e.g., automobile service stations), and other oper-
ations could be expected to increase the types and 
concentrations of petroleum products in ground-
water used for drinking and exposure of hwnans to 
the toxic effects of these chemical compounds. 
Petroleum products are persistent and highly 
mobile contaminants which are difficult to remove 
from groundwater. In addition, many of these 
chemicals are known or suspected carcinogens or 
mutagens which can pose undesirable human 
health risks (e.g., cancer, birth defects, and other 
chronic conditions) at 10 ppb and below (Council 
on Environmental Quality, 1980). There is a need 
for more research on the types and concentrations 
of petroleum products (e.g., benzene, toluene, 
ethylbenzene) found in public water supply wells 
used for drinking water and the immunotoxic and 
neurotoxic effects of these organic compounds. 
The objectives of this research project were: 
1. To characterize petrolewn products in raw 
water from wells used for drinking water 
in selected areas (industrial, commercial, 
and other) of Utah. 
2. To evaluate the toxicity of selected petro-
leum products in experimental animals, 
with emphasis on the following: 
a. Immunotoxic and hypersensitivity 
effects. 
b. Neurotoxic and behavioral effects. 
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Methodology 
Characterization of Petroleum 
Contaminants in Well Water 
Numerous well water sampling trips were 
conducted during the 1985-87 research project 
period. A total of 5 shallow USGS monitoring 
wells (depth to sediment: 12 to 14 feet) and 6 deep 
drinking water wells (140 to 380 feet deep) located 
over an area extending from Woods Cross, Utah, to 
Orem, Utah, were sampled for petroleum contami-
nants. All wells were located in the vicinity of 
petroleum refineries, gasoline stations, or other 
activities (e.g., steel manufacturing, explosives 
production, public works). 
After purging each well by evacuating a 
minimum of three well casing volumes, water 
samples for volatile and semi volatile organic pol-
lutant analyses were collected in duplicate or trip-
licate with a clean Teflon bailer or by hand, put 
into appropriate amber glass bottles with teflon 
septa and screw caps, and packed in ice coolers for 
transportation to the Utah Water Research Labora-
tory. At the laboratory, all samples were stored at 
4°C for later chemical analyses. Temperature, pH, 
and conductance of water samples collected in the 
field were measured and recorded. Temperature was 
measured with a YSI Model 33 S-C-T Meter, 
Orion SA 250 meter or a dry bulb thennometer. A 
Leeds and Northrup Model 7417 Meter or Orion 
SA 250 Meter were used to measure pH. Conduc-
tance was measured with a YSI Model 33 S-C-T 
Meter. 
All sampling equipment that would be in 
contact with well water was cleaned with Micro 
laboratory cleaning solution, washed thoroughly 
with tap or distilled water, rinsed several times 
with acetone, and then washed with distilled water 
before use. For each well where a bailer was used· 
to coHect water, samples for volatile organic pol-
lutants were obtained from the first bai1er of well 
water. Water samples for semi volatile organic 
pollutants were obtained from subsequent bailer 
well water samples which had been thoroughly 
mixed in a large stainless steel bucket. For each 
well where water samples were collected by hand, 
the well water was allowed to flow for about 30 
minutes before collection of water samples. 
Water samples were analyzed for traces 
of volatile organic petroleum pollutants by EPA 
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Purge and Trap Analysis Method 5030. Following 
extraction of the semivolatile organics in the water 
samples by solvent extraction (EPA Separatory 
Funnel Liquid-liquid Extraction Method 3510), the 
extractables (acids and base neutrals) were analyzed 
by EPA GC/MS Method 8250 for semivolatile 
organics--Packed Column Technique. 
A concentrated effort was made to locate and 
sample shallow drinking water wells (wells capable 
of drawing surface water into them) in areas where 
Leaking Underground Storage Tanks (LUST) were 
known or suspected. This task was a diffi uIt one. 
After consulting with water personnel at various 
agencies (e.g. North Davis, South Salt Lake City, 
and Provo County Health Departments, USGS 
Office in Salt Lake City, Bureau of Public Water 
Supplies in the State of Utah Department of 
Health, and Orem City's Engineering Office), it 
was apparent there are few, if any, shallow wells in 
the present study area that are used for drinking 
purposes. According to a Bureau of Public Water 
Supplies (Salt Lake City) engineer, there may be a 
few private shallow wells in the area we are 
studying that have not yet been inventoried and 
which are most likely used for agricultural irriga-
tion or live-stock watering purposes. There is a 
possibility some of these wells may be serving as 
a source of drinking water. 
Because of the above findings, we decided to 
collect water samples from shallow USGS moni-
toring wells and deep drinking water wells (wells 
that penetrate an impermeable strata and prevent 
surface water from being pumped or injected into 
them) in the study area where LUST were known 
or suspected. In future studies, more emphasis 
should be placed on obtaining water samples from 
shallow monitoring wells and nearby deep drinking 
water wells in those parts of a study area where 
LUST are known or suspected and then examining 
these samples for types and concentrations of 
petroleum contaminants. 
Toxic Effects of Selected Petroleum 
Contaminants in Laboratory Animals 
Toxicity studies were conducted from August 
25, 1985, through June 30, 1987. For the 1985-
86 project period, studies were perfonned to deter-
mine the immunotoxic and neurotoxic effects of 
selected petroleum contaminants, namely, benzene, 
toluene, and phenol in laboratory animals (mice) 
following continuous ingestion of drinking water 
containing various concentrations of tbe test 
cbemicals. 
For the 1986-87 project period. studies were 
conducted primarily to detennine the immunotoxic 
and neurotoxic effects resulting from tbe inter-
action of two petroleum contaminants. namely, 
benzene and toluene, in laboratory animals (mice) 
following continuous ingestion of drinking water 
containing combination concentrations of the two 
test chemicals. 
Benzene-induced immunotoxicity and 
neurotoxicity in mice 
Experiments were conducted to detennine the 
effects of benzene on the immune and nervous sys-
tems of mice. Analytical reagent grade benzene 
(99.9% purity, IT Baker Cbemical Co., Phillips-
burg, Nl), was dissolved in nonnal tap water to 
provide nominal concentrations of 40, 200, and 
1,000 mg/L. Benzene has a solubility of 1,780 
mg/L in water at 25°C (USBPA. 1980). The 
benzene-treated water was administered to male, 
adult CD-I mice (approximately 20-22 gm initial 
weight) continuously for 28 days via drinking 
water; the control group received untreated tap 
water. In addition to tbe benzene-treated tap water 
given as drinking water. all animals received lab 
chow. To minimize decomposition and to main-
tain the concentration of benzene. drinking water 
was provided in glass water botties. shaken fre-
quently during treatment and was changed every 3 
days. Feed and water consumption was monitored 
continuollsly, and animals were weighed once eacb 
week. Benzene concentration in drinking water 
was confinned on different days by gas chromato-
graphy (USEPA, 1982). The observed concentra-
tions for benzene were 31, 166, and 790 mg/L. 
Five mice per test group were housed in plas-
tic cages on bardwood-chip bedding and maintained 
on a 12 hour light-dark cycle at an ambient room 
temperature of 21 ± 1°C during tbe experimental 
period. All animals in the study were individually 
identified with color bands on their tails. 
To assess the general toxic effects of benzene 
in mice following continuous ingestion of drink-
ing water containing various concentrations of 
benzene, food. water consumption, and individual 
body weight gain were monitored throughout the 
experimental period. Relative organ (kidney. 
spleen, liver, and thymus) weights of each animal 
were recorded at the time of animal sacrifice. In 
addition to the above observations, tbe following 
immunotoxic evaluations were perfonned on the 
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test animals after 4 weeks of treatment to evaluate 
benzene-induced immtmotoxicity: I) Hematologi-
cal tests [e.g. red blood cell (RBC) and white blood 
cell (WBC) counts] to detennine benzene hema-
toxicity; 2) Mitogenesis Assay for inducing and 
measuring animal splenic lymphocyte proliferation 
in response to mitogens and antigens in vitro; 3) 
Mixed Lymphocyte Response (MLR) in whicb the 
mixing of two populations of allogeneic lymphoid 
cells (stimulator and responder ceUs) results in T 
cell proliferation; 4) Cell-mediated Cytolytic Re-
sponse to evaluate splenic lymphocytes of test ani-
mals for cytotoxic cells; 5) Plaque Fonning Assay 
(Cunningham and Szenberg, 1956) to evaluate the 
primary antibody response by mouse splenic lym-
phocytes toward sheep red blood cells (SRBC), a 
T -dependent antigen; and, 6) Enzyme Linked 
Immunosorbent Assay (ELISA) to detennine 
specific hemolysin. 
After 4 weeks of benzene treatment and for 
neurotoxic evaluations, five additional mice from 
the control and eacb of tbe test groups were killed 
by decapitation and their brains quickly dissected 
into six anatomic regions (hypothalamus, medulla 
oblongata, cerebellum, midbrain, corpus striatum, 
and cortex [Glowinsky and Iversen, 1966]). The 
midbrain included tbe hippocampus, thalamus, and 
subthalamus regions. Brain tissues were immedi-
ately placed into tared vials containing several 
volumes, in relation to tissue weight, of ice-cold 
0.05 M HCI04 with 0.5% cysteine and then frozen 
at -80°C until analyzed. To minimize possible 
diurnal variations in regional brain neurotrans-
mitter concentrations, all animals were sampled 
between 10:00 and 12:00 am. on the same day. 
Samples from various brain regions were 
homogenized and centrifuged at 10,000 g for 60 
minutes, and tbe supernatant fractions were passed 
through a 0.2 !.lm pore filter by gentle centri-
fugation for 3 minutes at 1000 g. These filtrates 
were analyzed for major catecholamines and indo-
leamines, namely dopamine (DA), norepinephrine 
(NE), 5-hydroxytryptamine (5-HT, serotonin), and 
their principal metabolites, i.e. dihydroxypbenyl-
acetic acid (DOPAC), homovaniUic acid (HV A). 3-
methoxy-4-hydtoxy-mandelic acid (VMA), and 5-
hydroxyindoleacetic acid (5-HIAA) using high 
pressure liquid chromatography with a multiple 
electrode electrochemical detector (Mayer and 
Shoup, 1983) to detennine possible changes in tbe 
levels of these selected neurotransmitters that 
control behavior. 
The neurocbemicals selected for evaluation 
are known to play an important role in physiology 
and behavior (poirier and Bedard, 1984; Rogawski 
and Baker, 1985). Changes in concentrations of 
their metabolites provide an appropriate indication 
of neura] activity (Commissiong, 1985). Assays in 
various brain regions are essential to detect 
perturbations of a specific neurotransmitter(s). 
The data were analyzed by one-way analysis 
of variance followed by the least significant differ-
ence test, if F ratios were significant. A P<0.05 
was accepted as statistically significant. 
Toluene-induced immunotoxicit.v 
and neurotoxicit.v in mice 
Experiments were also conducted to determine 
the effects of toluene on the immune and nervous 
systems of mice. Chromatography grade toluene 
(99.7% purity, Burdick and Jackson Labs, Inc., 
Mu."lkegon, MI) was dissolved.in normal tap water 
to provide nominal concentrations of 20, 100, and 
500 mg/L. Toluene bas a solubility of 535 mgIL 
in water at 25°C (USEPA, 1980b). The toluene-
treated water was also administered to the CD-I 
mice continuously for 28 days via drinking water; 
the control group received untreated tap water. 
These animals also received lab chow. To mini-
mize decomposition and to maintain the concen-
tration of toluene, drinking water was provided in 
glass water bottles, shaken frequently during treat-
ment and was changed every 3 days. Feedand 
water consumption was monitored continuously, 
and animals were weighed once each week. 
Toluene concentration in drinking water was also 
confirmed on different days by gas chromatography 
(US EPA, 1982). The observed concentrations for 
toluene were 17, 80, and 405 mg/L. 
As with the benzene study, five miCe per test 
group were housed in plastic cages on hardwood 
chip bedding and maintained on a 12 bour Iight-
dark cycle at ambient room temperature during the 
experimental period. All animals received lab 
chow and were individually identified with color 
bands on their tails. 
To assess the general toxic effects of toluene 
in mice following continuous ingestion of drink- . 
ing water containing various concentrations of 
toluene, food and water consumption, and indivi-
dual body weight gain were also monitored 
throughout the experimental period. The methods 
for evaluating toluene-induced immunotoxicity and 
neurotoxicity in mice were the same as those used 
for benzene. 
Phenol-induced immunotoxici!y and 
neurotoxicity in mice 
Experiments were also conducted to determine 
the effects of phenol on the immune and nervous 
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systems of mice. Analytical reagent grade phenol 
was dissolved in normal tap water to make the 
nominal concentrations of 5, 20, and 100 mgIL. 
Phenol has a solubility of approximately 67 gIL 
(Windholz, 1976). The phenol-treated water was 
administered to the CD-I mice continuously for 28 
days via drinking water; the control group received 
untreated tap water. In addition to the phenol-
treated tap water given as drinking water, all ani-
mals received lab chow. 
To minimize decomposition and maintain the 
concentration of phenol, drinking water was pro-
vided in glass water bottles, shaken frequently 
during treatment and changed every 3 days. Feed 
and water consumption was monitored continuous-
ly, and animals were weighed once each week. 
Phenol concentration in drinking water was 
confirmed on different days by the direct 
photometric method (APHA, 1980). Observed 
concentrations for phenol were approximately 95 
percent of the nominal concentrations (4.75, 19, 
and 95 mg/L) used. 
Similar to the benzene and toluene studies, 
five mice per test group were housed in plastic 
cages on hardwood chip bedding and maintained on 
a 12 hour light-dark cycle at ambient room 
temperatnre during the experimental period. All 
animals also received lab chow and were 
individually fitted with color bands on their tails. 
The methods for assessing the general toxic 
effects of phenol in mice following continuous 
ingestion of drinking water containing various 
concentrations of phenol and for evaluating 
phenol-induced immunotoxicity and neurotoxicity 
in mice were the same as those used for the 
benzene and toluene studies. 
Effect of benzene. and toluene. alone or com-
bined on immunotoxicity and neurotoxicity in 
mice. 
Experiments have been conducted to deter-
mine the effects of combinations of benzene and 
toluene on the immune and central nervous 
systems of mice. Male, adult, CD-l mice were 
separ-ated into four groups (five mice pet group): 
1) control group exposed to untreated tap water; 2) 
benzene group exposed to benzene-treated tap 
water; 3) toluene group exposed to toluene-treated 
water ;and, 4) mixture group exposed to a mixture 
of benzene and toluene in tap water. Two 
experiments were performed. 
In the first experiment, the animals were 
exposed to 200 mg/L benzene, 400 mg/L toluene, 
and 200 mg/L benzene + 400 mg/L toluene. In 
the second experiment, the animals were exposed 
to 200 mg/L benzene, 100 mg/L toluene, and 200 
mg/L benzene + 100 mg/L toluene. The animals 
were continuously fed tap water ad. lib., containing 
the various concentrations of benzene, toluene, and 
benzene + toluene for 4 weeks. The animals were 
housed, maintained, and identified with color bands 
on their tails as in the other toxicity studies. 
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To assess the general toxic effects in mice, 
food and water consumption were monitored con-
tinuously, and animals were weighed once a week. 
The methods for evaluating the effects of combi-
nations of benzene and toluene on the immune and 
central nervous systems of mice were the same as 
those used for the benzene, toluene, and phenol 
toxicity studies. 
Principal Findings and Significance 
This portion of the final research project 
report has been chronologically divided into the 
following parts: 1) characterization of petroleum 
contaminants in well water; 2) benzene~induced 
immunotoxicity and neurotoxicity in mice; 3) 
to1uene~induced immunotoxicity and neurotoxicity 
in mice; 4) phenol-induced immunotoxicity and 
neurotoxicity in mice; 5) immunotoxic effects of 
benzene (200 mg/L), toluene (400 mg/L), and a 
mixture of benzene (200 mg/L) + toluene (400 
mg/L) in mice; 6) immunotoxic effects of benzene 
(200 mg/L), toluene (100 mg/L), and a mixture of 
benzene (200 mg/L) + toluene (100 mg/L) in 
mice; 7) neurotoxic effects of benzene (200 mg/L), 
toluene (400 mg/L), and a mixture of benzene (200 
mgIL) + toluene (400 mg/L) in mice; and 8) 
neurotoxic effects of benzene (200 mg/L), toluene 
(100 mg/L), and a mixture of benzene (200 mg/L) 
+ toluene (100 mg!L) in mice. In the interest of 
clarity and conciseness, the data are summarized 
and presented in tabular form (see Appendix A for 
tables) and results are discussed as they are 
presented 
Characterization of Petroleum 
Contaminants in Well Water 
Table I shows the temperature, pH, and/or 
conductance values of well water samples collected 
from five USGS shallow monitoring wells during 
the 1985-1987 research project period. Water tem-
peratures ranged from 6.8 to 18.0°C. The pH of 
the water samples ranged from 5.5 to 7.8. Con-
ductance values O.unhos/cm) ranged from 1,339 to 
5,105. Temperature and pH values of well water 
samples collected from six deep drinking water 
wells during the project period are presented in 
Table 2. Water temperatures for these samples 
ranged from 12.8 to 19.4°C. The pH of the water 
samples ranged from 6.2 to 7.4. 
Results of volatile or semivolatile organic 
pollutant analyses of various shallow monitoring 
well water samples collected during the 1985-87 
project period are presented in Table 3. Volatile 
organic compounds detected in the shallow well 
water samples by Purge and Trap Analysis (Table 
3) were: benzene (0.81-196.83 I1g/l), toluene 
(0.09-122.33 I1g/l), ethyl benzene (0.96~101.27 
I1g/J), p-xylene (0.25-26.98 I1g/l), m-xylene 
(0.29-8.36 I1g/l), o-xylene (0.31-3.08 I1g/l), 1,3,5-
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trimethylbenzene (5.36-62.45 I1g/l), 1,2,3;4-tetra-
methylbenzene (5.83-9.49 I1g/l), 1,2,4,5-tetra-
methylbenzene (1.27-10.46I1g/l), and naphthalene 
(4.14-6.71 I1g/l). Volatile or semivolatUe organic 
compounds detected in the shallow well water sam-
ples by Methylene Chloride Extraction (Table 3) 
were: Benzene (1.83-36.21 I1g/l), toluene (1.13-
17.39 I1g/l), ethylbenzene (17.89-53.23 I1g/l), p-
xylene (0.48 I1g/l), 1,2,3,4,.tetra-methylbenzene 
(9.57 I1g/l), 1,3,5-trimethylbenzene (15.22-21.06 
I1g/l), and I-methylnaphthalene (4.96 I1g/l). 
Benzene (0.81-196.83 Ilg/J), toluene (0.09-
122.33I1g/l), ethylbenzene (0.96-101.29I1g/l), and 
o-xylene (0.31-3.08 I1g/l) were detected in well 
water samples from three shallow monitoring 
wells (Well numbers 3, 4, and 5) which were 
located near gasoline pumps. A level up to 6.4 
mg/L toluene has been detected in drinking water 
(Tardiff and Youngren, 1986). Benzene, toluene, 
ethylbenzene and o-xylene are known chemical 
constituents of gasoline. 
Well number 3 was located at the Sandy 
Public Works Department (8775 South 700 West, 
Sandy, Utah). Three gasoline pumps were located 
. 90 to 100 feet east of the monitoring well. Well 
number 4 was located in a parking lot approxi-
mately 105 feet north of a Sinclair gas station at 
7000 South 2000 East, Salt Lake City, Utah. 
Well number 5 was located in an apartnient com-
plex at 450 South, 945 East, Salt Lake City, 
Utah. A Ge/MS analysi., of water samples from 
well number 3 indicated the presence of numerous 
other organic compounds as shown in Table 4. 
The following organic compounds were also detec-
ted in water from well number 3: p-xylene (0.25-
26.99 I1g/l), 1,3,5-trimethylbenzene (12.23-62.45 
I1g/l), 1,2,3,4- tetramethylbenzene (5.83-9.49 
I1g/l), 1,2,4,5-tetramethylbenzene (1.27-13.96 
I1g/l), m-xylene (0.29 I1g/l), and naphthalene 
(4.14-5.18 11811). In water from well number, 4 
other organic compounds detected were: .p-xylene 
(6.50 I1g/l), m-xylene (2.49 I1g/l), 1,3,5-trimethyl-
benzene (2.68 I1g/l), 1,2,4,5- tetramethylbenzene 
(2.66I1g/l), and naphthalene (3.36 I1g/l). In water 
from well number 5 other organic compounds 
detected were: p-xylene (14.54 I1g/l), m-xylene 
(8.36 I1g/l), 1,3,5-trimethylbenzene (6.70 I1g/l), 
1,2.4,5-tetramethylbenzene (6.90 I1g/l), and naph-
thalene (4.81 I1g/l). Surprisingly, although not 
detected by Purge and Trap Analysis during the 
first sampling trip (9/09/85), toluene (1.13 I1g/1), 
1,2,3,4-tetramethylbenzene (9.57 I1g/l), and 1-
metbylnapbtbalene (4.96 Ilg/l) were detected by 
Methylene Chloride Extraction in water from well 
number 2 during tbe second sampling trip 
(02/06/86). The shallow monitoring well from 
which this water sample was collected is located 
adjacent to a private residence and about one and 
one-half blocks southwest of a public gasoline 
station. Benzene (17.98 Ilg/l) was detected by 
Purge and Trap Analysis in water from well num-
ber 2 during a later sampling trip (04/2A/87). 
No volatile or semivolatile organic com-
pounds were detected in any of the deep well water 
samples collected during the entire research project 
. period. Table 5 shows the organic compounds 
detected by GC/MS analysis of all shallow moni-
toring well water samples analyzed during the 
study. 
Benzene-induced Immunotoxicity and 
Neurotoxicity in Mice 
Benzene-induced immunotoxicity in mice 
Continuous exposure of adult CD-I mice to 
various concentrations of benzene (0, 40, 200, 
1000 mg/L) via drinking water over a 4 week 
period did not cause mortality or induce any clini-
cal toxicity signs in the animals. Overall, there 
was no change in total feed and water consump-
tion; bowever, water consumption by mice in the 
1000 mg/L treatment group was slightly decreased. 
No gross lesions were observed on any of the 
organs of mice in all treatment groups at the time 
of sacrifice. There was also no significant change 
in body weight gain (Table 6). 
Table 7 shows the organ and body weigbts of 
mice following 4 weeks of benzene exposure. 
Spleen and thymus decreased in weight at all the 
benzene concentrations. Spleen showed a signifi-
cant decrease in weight at the 1000 mg/L level. 
Kidney increased in weight at all the concentra-
tions and sbowed a significant increase in weight at 
the 1000 mg/L level. 
The effects of 4 weeks of benzene exposure 
on spleen cellularity and selected blood parameters 
are presented in Table 8. Total spleen cellularity 
decreased significantly at the 1000 mg/L level. It 
can be seen from tbe table that WBC and RBC 
counts decreased significantly with increased dose. 
PCV also decreased significantly at the 200 and 
1000 mg/L concentrations. Benzene is a proven 
hemotoxin (Fishbein, 1984). In man, it is 
causally related to pancytopenia (USEPA, 1980). 
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From the differential WBC counts sbown in 
Tahle 8, it can be seen that there was a significant 
depression of lymphocytes at 40 and 1000 mg/L, 
and a significant stimulation of neutropbils at 
tbese two concentrations. While all blood cell 
types are targets for benzene poisoning, lympho-
cytes are particularly sensitive (Rosenthal and 
Snyder, 1985). 
Table 9 shows tbe effects of benzene expo-
sure on the uptake of (=4H]-thymidine by mouse 
spleen cells in culture. Spleen cells are evaluated 
for their ability to proliferate after mitogen stimu-
lation. Following four weeks of exposure, the 
proliferative response of mitogen-treated spleen 
cells is biphasic, significantly elevated in low dose 
(40 mg/L) group and significantly decreased in 
higher dose (200, 1000 mg/L) groups. The results 
of the mixed lymphocyte response to allogeneic 
cells (Table 10) are the same as the mitogenesis 
results (Table 9), and there are also significant 
differences. 
The killing of target cells by sensitized T-
lymphocytes is an important indicator of cell-
mediated immunity. Tbe effect of benzene 
exposure on cell-mediated cytolytic response is 
shown in Table II. The results of SlCr-reJease 
assay show that cell-mediated cytolytic response 
against tumor cells (target cells) is affected by 
benzene exposure. The response is also biphasic, 
elevated in low dose (40 mg/L) group and decreased 
in high dose (200, 1000 mg/L) groups. There is 
a significant depression in response at the 200 
and 1000 mg/L levels in the 50:1 effector-to-target 
cell ratio. The results for the 25:1 ratio also 
showed significant stimulation in the 40 mg/L 
group, but significant suppression only at the 
1000 mg/L level. 
After 4 weeks of benzene exposure via 
drinking water, animals were injected with sheep 
red blood cells (SRBC) and their anti-SRBC 
antibodies evaluated by enumeration of plaque-
forming cells (PFC). The effect of 4 weeks of 
benzene exposure on the antibody plaque-forming 
cells (PFC) is presented in Table 12. The results 
of primary antibody response show that there is a 
significant depression of plaque formation by cells 
collected from animals exposed to 200 and 1000 
mg/L benzene in drinking water and no significant 
stimulation in the 40 mg/L group. The titer of u-
SRBC antibodies corresponds with the changes in 
numbers of PFC. According to the EUSA tests, a 
significant inhibition was found at the highest dose 
(1000 mg/L) group (Table 12). 
BeD7..ene-induced neurotoxicity in mice 
The regional concentrations of catechol a-
mines and indoleamines in different brain regions 
are presented in Tables 13, 14, 15 and 16. 
Ingestion of benzene in drinking water induced 
significant increases in catecholamine neuro-
transmitters in several brain regions at all three 
benzene-treated levels when compared with control 
animals (Tables 13 and 14). 
The significant benzene-induced increases of 
concentrations of NE relative to controls were 
found in the hypothalamus (200, 1000 mg/L), 
medulla oblongata (200 mg/L), cerebellum (1000 
mg/L), midbrain (40, 200, and 1000 mg/L) and 
cortex (40, 200 and 1000 mg/L). The concen-
tration of VMA, a metabolite of NE, also showed 
a significant increase in the cerebellum, corpus 
striatum and cortex (40, 200 and 1000 mg/L). 
DA, the parent neurotransmitter of dopaminergic 
neuronal systems, exhibited a moderate increase in 
various brain regions but this finding was not 
significant. 
Significant increases in the OOPAC 
concentration, one metabolite of OA, were found 
in the hypothalamus (200 mg/L), and in other 
brain regions such as the medulla oblongata (40, 
200 mg/L), midbrain (40, 200, and 1000 mg/L), 
corpus striatum (1000 mg/L), and cortex (40, 200 
mg/L). HV A, the last step metabolite of OA, was 
also significantly increased in the midbrain (40, 
200, and 1000 mg/L). Likewise, there were 
significant increases of HV A in the corpus 
striatum (1000 mg/L) and in the cortex (40, 200 
mg/L). No significant increases of HVA 
concentrations were found in the other brain 
regions (hypothalamus, medulla oblongata, and 
cerebellum). 
Benzene ingestion also induced significant 
increases in indole amine neurotransmitters in 
several brain regions (Tables 15 and 16). The 
levels of 5-HT were significantly increased in 
midbrain (all treatment groups), cortex (40, 200· 
mg/L), and medulla oblongata (40 mg/L), the 
regions of the brain containing relatively high 
amounts of this amine. Concommitant with the 
observed increases of 5-HT concentrations, levels 
of its metabolite (5-HIAA) were likewise 
significantly increased in the same brain regions 
and the same dose groups. These [mdings of 
alterations in brain neurotransmitter concentrations 
may support the reported clinical and behavioral 
effects associated with benzene exposure (Haley, 
1977; Brief et al., 1980; Evans et al., 1981; 
Dempster et al., 1984). 
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Toluene-induced Immunotoxicity and 
Neurotoxicity in Mice 
Toluene induced immuootoxicity in mice 
Continuous exposure of CD-l male mice to 
various concentrations of toluene (0, 20, 100,500 
mg/L) via drinking water over a 4 week period did 
not induce mortality or overt signs of toxic stress. 
Overall, a dose-related slight decrease of total food 
commmption was observed; however, there was no 
change in total water consumption. No gross 
lesions were found on any of the organs of mice in 
all treatments groups at the time of sacrifice. 
There was also no change in body weight gain 
(Table 17). 
Table 18 shows the organ and body weights 
of mice following 4 weeks of toluene exposures. 
The weight of liver was significantly increased in 
the two higher dosed groups (100, 500 mg/L). 
Thymus, the primary lymphatic tissue, showed a 
significant decrease in weight at the 500 mg/L dose 
level. Spleen and kidney showed no change in 
weight during the experiment 
The effect<; of 4 weeks of toluene exposure on 
spleen cellularity and selected blood parameters are 
given in Table 19. Total spleen cellularity did not 
show significant decrease in any of the treatment 
groups. The hematological data demonstrated a 
significant decrease in peripheral leukocytes at the 
highest dose level (500 mg/L) and a slight increase 
in the other two toluene-treated groups (20, 100 
mg/L). Hobara et al., (1984), observed significant 
leukocyte decreases in mature cross-breed dogs 
exposed by inhalation to more than 500 ppm 
toluene. 
From the differential WBC counts shown in 
Table 19, it can be seen that there was no signifi-
cant depression of lymphocytes with increased dose 
and only a slight increase in neutrophils. No 
change of monocytes was found in all the treated 
groups when compared to the control group. There 
is general agreement that toluene does not have the 
hematotoxic properties of benzene (Fishbein, 
1985, U.S. EPA, 1980b). 
Table 20 shows the effects of toluene 
exposure on the uptake of [3H]-thymidine by either 
mitogen stimulated or nonmitogen stimulated 
mouse splenic cells in cultures after 4 weeks of 
treatment. A significant decrease in [3H]-thymi-
dine incorporation in non-mitogen stimulated cul-
tures was observed at all dose levels in the in vivo 
toluene-treated splenic cells. There also appeared 
to be a depressing mitogenesis response to all 
mitogens, i.e. LPS, PWM, ConA, and PHA. 
Statistical analysis revealed significant 
differences from controls at 20, 100, and 500 
mg/L toluene dose levels. From these findings, 
toluene was shown to have a significant depressing 
effect on the mitogenic response to both T cell 
mitogens (ConA, PHA) and B cell mitogens (LPS, 
PWM). 
Table 21 demonstrates the lymphocyte-
transformation response to allogeneic cells. 
Similar to mitogenesis, a significant reduction of . 
[3H]-thymidine incorporation occurred in non-
stimulated and allogeneic cell cultures in all 
toluene-treated mice splenic cells. These results 
show that toluene depressed T cell function in 
response to allogeneic cells. 
The effects of toluene exposure on cell-
mediated cytolytic response are presented in Table 
22. The results of 51Cr-release assay show that 
cell-mediated cytolytic response against tumor cells 
(target cells) is moderately affected by toluene 
exposure. The decreased responses are a dose-
related effect. A significant reduction was only 
seen at the highe.~t dose levels (500 mg/L) in the 
50:1 effector-to-target cell ratio. 
After 4 weeks of toluene exposure via drink-
ing water, our studies demonstrated that toluene 
causes an immunosuppressive effect by decreasing 
the development of SRBC-specific plaque-forming 
cells (fPC) (Table 23). This immunosuppression 
was a dose-related effect but the significant sup-
pressions were only found in the 500 mgIL 
toluene-treated group. The results of ELISA test 
showed that the titer of a-SRBC antibodies did not 
decrease significantly (Table 23). 
Toluene-induced neurotoxicity in mice 
The levels of toluene used in this study did 
not cause the animals to display noticeable clinical 
behavioral effects during the course of the experi-
ment. After 4 weeks of toluene treatment via 
drinking water, toluene ingestion induced signifi-
cant increases in catecholamine neurotransmitters 
in several brain regions. The effects were often 
maximal at 100 mg/L with no further increase 
apparent at the highest dose (Tables 24 and 25). 
Toluene exerts its greatest effect on NE. In 
the hypothalamus, a region especially rich in this 
neurochemical, significant toluene-induced 
increases were detected relative to the control 
group in all three treatment groups. The three 
doses of toluene also caused significant increases 
in concentrations of NE in the midbrain, one major 
region containing relatively high amounts of 
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this amine. Likewise, a significant increase in NE 
concentrations was seen in the medulla oblongata 
in the 100 mg/L group (Table 24). 
The apparent increases of NE in the other 
three brain CODlpartments (cerebellum, corpus stri-
atum, and cortex), the regions with lower amounts 
of NE, were not significant as determined by 
analysis of variance. The concentration~ of VMA, 
a major metabolite of NE, were also influenced by 
toluene treatment. It can be seen that there were 
significant increases of VMA in midbrain and 
corpus striatum at the two highest doses (100, 500 
mg/L), medulla oblongata at the J 00 mg/L, and 
cortex in the 500 mg/L group (Table 25). 
Levels of DA and its principal metabolites, 
namely, DOPAC and HV A, showed significant 
increases in several brain regions following 4 
weeks of toluene treatment. For example, in the 
corpus striatum, a region with the highest concen-
trations of these three neurotransmitters, there were 
significant increases of DA in the two higher dosed 
groups and of HV A in the highest dosed group. 
Concentrations of DA were also significantly 
increased in the hypothalamus at all three toJuene 
doses. DOPAC showed a significant increase in 
the medulla oblongata and HV A in the cerebeUum 
at the 100 mg/L dose. The medulla oblongata and 
the cerebellum are two brain regions containing 
relatively low concentrations of DOPAC, DA, and 
HV A. DOPAC also showed a significant increase 
in the hypothalamus at the 20 and 100 mg/L 
doses. 
Toluene ingestion also induced significant 
increases in indoleamine neurotransmitters, 5-HT 
and its major metabolite 5-HIAA (Tables 26 and 
27). Remarkable changes were observed in 5-lIT 
concentrations. There were significant increases of 
5-lIT in all brain regions except the cerebellum 
where 5-HT occurs in small amounts. Significant 
increases of 5-lIT were found in hypothalamus 
(100 mg/L), medulla oblongata (100,500 mg/L). 
midbrain (20, 100, and 500 mg/L), corpus striatum 
(100, 500 mg/L), and cortex (20. 100, and 500 
mg/L). Concommitant with the observed increases 
of 5-HT concentrations. concentrations of 5-HIAA 
also increased, primarily in the 100 mg/L dose 
groups such that significant increases of this 
chemical occurred in the hypothalamus, medulla 
oblongata, and cortex regions of the brain. 
The neurotoxic properties of toluene represent 
the main health hazards (Fishbein, 1985). The 
study results suggest that toluene has an effect on 
adrenergic, dopaminergic. and serotonergic path-
ways. These observations support the hypothesis 
that physio-chemical properties of toluene may 
lead to changes in membrane fluidity. 
Phenol-induced Immunotoxicity and 
Neurotoxicity in Mice 
Phenol-induced immunotoxicity in mice 
Continuous exposure of adult, CD-l mice to 
various concentrations of phenol (0, 5, 20, 100 
mg/L) via drinking water for 4 weeks had no effect 
on total food and water consumption or on hody 
weight gain (Table 28). However, 4 weeks of ex-
posure· did result in non-significantly decreased 
spleen, thymus, and liver weights and increased 
kidney weight (Table 29). No gross lesions were 
observed on any of the organs of mice in all treat-
ment groups at the time of sacrifice. 
The effects of 4 weeks of phenol exposure on 
spleen cellularity and selected blood parameters are 
given in Table 30. Total spleen cellularity did not 
sbow a significant decrease in any of the treatment 
groups. Phenol exposure resulted in a dose-depen-
dent decrease in peripheral red blood cell counts and 
the change was significantly different in all treat-
ment groups when compared to controls. A simi-
lar decrease was seen in leucocyte counts, but the 
decrease was not significant. The cbange in packed 
cell volume (PCV) exhibited a significant decrease 
in the highest dose group (100 mg/L) only. From 
the differential WBC counts shown in Table 30, it 
can be seen that there was no treatment-related 
effect on lymphocytes, neutrophils, and monocytes 
when compared to the control group. 
Table 31 shows tbe effect of a 4-week pbenol 
exposure on the uptake of [3H]-thymidine by 
mouse splenic cells. Exposure of mice to phenol 
resulted in a significant depression of lymphocyte 
blastogenesis in splenic cell cultures without 
mitogen at all dose levels tested. There also 
appeared to be a depressing mitogenesis response 
to all selected mitogens i.e., LPS (a murine B-cell 
mitogen), Con A (a T-cell mitogen), PWM (a T-
and B-cell mitogen) and PHA (a T-cell mitogen). 
From the uptake of [3H]-thymidine by mice 
splenic lymphocyte cultures as shown in Table 31, 
phenol exposure resulted in a significant suppres-' 
sion of B lymphocyte blastogenesis in all dose 
groups (LPS) and T lymphocyte blastogenesis in 
the 20 and 100 mg/L groups (PHA) and in the 5 
and 20 mg/L (Con A) groups. A similar trend was 
also observed with PWM mitogens-stimulated 
lymphoblastogenesis of splenic lymphocytes in all 
dose groups. 
The effects of various concentrations of 
phenol exposure via drinking water on T-cell proli-
feration of mice splenic lymphocytes in response 
to mixed lympbocyte culture are shown in Table 
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32. A significant reduction of [3H]-tbymidine 
incorporation occurred in allogeneic cell cultures in 
all pbenol-treated mice splenic cells. Similar 
responses were found in non-stimulated cultures 
but tbere was no significant difference from 
control. These findings show that phenol depres-
ses T-cell function in response to allogeneic cells. 
Results of StCr release assays suggest that 
cell-mediated cytolytic response against tumor cells 
was not affected by phenol exposure (Table 33). 
After 4 weeks of phenol exposure via drink-
ing water, the studies demonstrated that phenol 
causes a statistically significant immunosuppres-
sive effect at the two highest doses (20, 100 mg/L) 
by decreasing the development of SRBC (sheep red 
blood cell)-specific antibody plaque forming cells 
(PPC) (Table 34). From the ELISA study, the 
titer of a-SRBC antibodies was decreased signifi-
cantly in the 20 and 100 mg/L dosed groups and 
corresponded quite well with the reduction of 
antibody production assessed by the number of 
plaque-forming cells. 1bis a-SRBC response is a 
primary immune response arbitrated by the IgM 
class antibody. 
Phenol-induced neurotoxicity in mice 
At the doses administered. mice showed no 
apparent clinical behavioral effects during the 
period of tbese studies. After 4 weeks of phenol 
exposure via drinking water, the levels of catecho-
lamine and indoleamine neurotransmitters and their 
major metabolites were measured in six different 
brain regions. In most cases, phenol ingestion 
caused a dose-related decreased response (Tables 35, 
36, 37 and 38). Significant changes in these 
selected neurotransmitters occurred in several bmin 
regions. However, the effects were not often 
exhibited in the lowest dose group (5 mg/L). 
The greatest effect of phenol on ~he major 
biogenic brain amines was in the hypothalamic 
region. The concentration of norepinephrine (NE) 
showed a significant decrease at the two higber 
dose levels (20,100 mg/L). VMA, a major meta-
bolite of NE, was influenced moderately QY phenol 
exposure (TabJe 35). The indole amine, 5-HT, and 
its metabolite 5-HIAA were decreased significantly 
in the high exposure groups [20, 100 mg/L] (Table 
37). The hypotbalamic region is rich in these four 
biogenic amines. Significant changes of dopamine 
and its metabolite, DOPAC, in the hypothalamus 
were not induced by phenol ingestion (Table 35). 
The effects of phenol treatment were also 
obvious in the corpus striatum region. The levels 
of DA in this region were decreased significandy in 
all treatment groups. The corpus striatum is a 
brain region rich in DA (Table 36). The 5-RT 
levels were significantly decreased in the highest 
treatment dose (Table 38). The concentration of 
VMA was also significantly decreased in the 
100 mg/L group but its parent chemical, NE, 
was not significantly decreased at this level (Table 
36). 
The concentration of 5-Hf was also signifi-
cantly influenced by phenol exposure via drinking 
water in the midbrain and medulla oblongata, the 
regions containing relatively high amounts of this 
amine (Table 37, 38). In other brain regions, the 
levels of these seven selected neurotransmitters 
were not significantly decreased, except for the 
concentration of VMA in cortex, and showed a 
dose-dependent response. The levels of HV A, the 
last metabolite of DA, were not detected or low in 
each group in the hypothalamus, meduJIa oblon-
gata and cerebellum due to the fact that these three 
brain regions contain relatively low amounts of 
this chemical. 
The results of these studies indicated that 
phenol exposure via drinking water can induce a 
decrease in the levels of all these selected neuro-
transmitters, and the concentration alteration may 
be responsible for the reported encephalopathic 
effect of phenol exposure (Windus-Podehl et al., 
1983). 
Immunotoxic Effects of Benzene (200 mg/U, 
Toluene <400 mglL) and a Mixture of Benzene 
<200 mgIL) + Toluene (400 mgIL) in Mice 
Continuous exposure of adult male CD-l 
mice to benzene (200 mg/L), toluene (400 mg/L) 
and a mixture of benzene (200 mg/L) + toluene 
(400 mg/L) via drinking water for 4 weeks did not 
produce overt clinical symptoms of toxicity in the 
experimental animals. Overall, there was no 
change in food and water consumption. At the ter-
mination of the study, no significant increase in 
body weight gain was observed in the benzene (200 
mg/L) only or mixture (200 mg/L benzene + 400 
mg/L toluene) treatment groups when compared to 
controls. However, there was a significant increase 
in body weight gain in the toluene (400 mg/L) 
only treatment group when compared to untreated 
controls. The weight gain in this group was sig-
nificantly different from that in the mixture group 
(Table 39). In addition, the exposures resulted in 
decreased spleen and thymus weights and increased 
liver and kidney weights in all treatment groups. 
Thymus weight showed a significant decrease in 
the benzene (200 mg/L) only treatment group 
when compared to controls (Table 40). 
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The effects on selected hematological para-
meters of exposures to benzene, toluene and a 
mixture of benzene + toluene are given in Table 
41. Erythrocytes decreased significantly in the 
benzene (200 mg/L) group when compared to 
controls. In contrast, there was little change in 
erythrocytes in the toluene (400 mg/L) and mixture 
(200 mg/L benzene + 400 mg/L toluene) groups 
when compared to controls. When compared to the 
mixture group (Table 41), the decrease in 
erythrocytes in the ben:r.ene only treatment group 
was antagonized by toluene. 
Erythrocytes increased significantly in the 
mixture group when compared to the benzene only 
treatment group. The blood leukocyte counts and 
leukocyte differentials also exhibited similar 
antagonized effects in the above treatment groups, 
Exposures to mixtures of chemically related sub-
stances are frequently encountered. In such cases 
the balance between different pathways of meta-
bolism for chemicals could be radically changed 
(Sipes and Gandolfi, 1986). 
Toluene has been shown to alleviate benzene-
induced hematotoxicity (Andrews et al., 1977), 
One possible explanation for this phenomenon is 
that toluene competitively inhibits the biotrans-
formation of benzene (Ikeda et al., 1972; Andrews 
et al, 1977; Gilmour et al., 1986). However, the 
toluene only treatment did not have a noticeable 
effect on the selected blood parameters when com-
pared to control animals. 
Table 42 shows the effect of a 4-week 
exposure on total spleen cellularity and the mito-
gen-induced splenic lymphocytic proliferations. 
FoHowing 4 weeks of treatment, the proliferative 
responses of either mitogen. stimulated or non-
mitogen stimulated splenic lymphocytes were 
depressed in the benzene (200 mg/L) and toluene 
(400 mg/L) groups and increased in the mixture 
group, but there was no statistically significant 
difference between the toluene only treatment 
group when compared to controls. Total spleen 
cellularity revealed a similar phenomenon, but did 
not change significantly in any of the treatment 
groups. 
The effects on T-cell proliferation of mice 
splenic lymphocytes in response to mixed 
lymphocyte culture (MLC) are shown in Table 43. 
Inhibition of [3H]-thymidine uptake occurred in 
allogeneic cell cultures in the benzene (200 mg/L) 
and toluene (400 mg/L) treatment groups. In 
contrast, [3Hl-thymidine uptake was elevated in the 
mixture group. This response was also observed 
in the "responder only" (non-stimulated) culture. 
The results presented in Table 44 demonstrate 
that exposure of mice to benzene (200 mg/L) 
significantly impaired the capacity of the cyto-
toxic-T lymphocyte to lyse target cells (YAC-l 
tumor cells) after 4 weeks of oral ingestion. 
However, this response was antagonized by toluene 
and showed a significant increase in the mixture 
group. There were no significant depressions of 
cytotoxic T -lymphocyte activity in the toluene 
(400 mg/L) group when compared to the control 
group .. 
The antibody production response to sheep 
red blood cell (SRBC) assessed by enumeration of 
the SRBC-specific plaque-forming cells (PFC) and 
the alterations of a-SRBC antibody titers are 
presented in Table 45. As shown in Table 45, 
there was a marked change in the ability of treated 
animals to produce SRBC-specific antibody. The 
numbers of PFC showed a significant decrease in 
benzene (200 mg/L) and toluene (400 mg/L) 
treatment groups and a significant increase in the 
benzene (200 mg/L) plus toluene (400 mg/L) 
group. The a-SRBC antibody titer corresponds to 
changes in numbers of PFC with a significant 
increase in the benzene (200 mg/L) + toluene (400 
mg/L) group. 
Immunotoxic Effects of Benzene (200 mgIL), 
Toluene <100 mglL) and a Mixture of Benzene 
(200 mglL) + Toluene (100 mgIL) in Mice 
Continuous exposure of adult CD-l mice to 
benzene (200 mg/L), toluene (100 mg/L) and a 
mixture of benzene (200 mg/L) + toluene (100 
mg/L) via drinking water for 28 days was per-
formed to evaluate the immunotoxic effects in CO-
l mice. 
There was no significant change in body 
weight gain during the exposure period in all the 
treatment groups when compared to the control 
group (Table 46). Total food and water consump-
tion was not affected in all treatment groups. The 
relative organ weights for spleen and thymus de-
creased in the benzene only and mixture treatment 
groups when compared to control animals.· 
Thymus weight showed statistically significant 
changes in these treatment groups compared to 
controls (Table 47). Depression of spleen and 
thymus weights was not observed in mice exposed 
to 100 mg/L toluene. No changes in liver and kid-
ney weights were found in all experimental groups 
(Table 47). 
Red blood cell counts were significantly 
depressed in the benzene (200 mg/L) group when 
compared to untreated controls. In contrast, a sig-
nificant increase in RBC counts was found in the 
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mixture group when compared to the benzene only 
treatment group (Table 48) .. No differences in 
spleen cellularities were detected except in the 
group treated with 200 mg/L benzene, but this 
depression was not statistically different from the 
control group (Table 48). 
Table 49 shows the effects of exposures to 
benzene (200 mg/L), toluene (100 mg/L) and a 
mixture of benzene (200 mg/L) + toluene (100 
mg/L) on splenic lymphocyte proliferations to the 
various mitogens. When compared to the untreated 
controls, the DNA synthesis (cell proliferations) of 
splenic cells was decreased in either non-mitogen 
stimulation or mitogen stimulation in all treat-
ment groups and showed a significant depression in 
the 200 mg/L benzene (LPS, Con A), 100 mg/L 
toluene (LPS), and the mixture groups (LPS, Con 
A). However, no interaction effects on mitogenic 
respon'lCs were found between the mixture and ben-
zene or toluene treatment only groups. 
The results of mixed lymphocyte responses 
are shown in Table 50. A significant depression in 
mixed lymphocyte responses was observed only in 
the studies of responder-to-stimulator ratio at 2:1 
and 4: 1 in all treatment groups when compared to 
controls. There was also no interaction effects 
observed in the mixture group when compared to 
the benzene or toluene only treatment groups. 
In conclusion, our immunotoxic studies of 
benzene and toluene interactions in CD-l mice 
have shown that a high dose of toluene (400 mg/L) 
has remarkable alteration effects on the immuno-
toxicity of benzene at a 200 mg/L concentration 
when administered in combination to adult, male 
CD-I mice via continuous ingestion of drinking 
water. The same alteration effects were not 
observed with the low dose of toluene (100 mg/L) 
in combination with benzene (200 mg/L). 
Neurotoxic Effects of Benzene (200 mglL1 
Toluene (400 mglL) and a Mixture of Benzene 
(200 mglL) + Toluene (400 mgIL) in Mice 
After 4 weeks of oral exposure via· drinking 
water at the doses employed, no clinical behavioral 
signs were observed in any of the treatment groups 
including those animals exposed to a mixture of 
benzene (200 mg/l) and toluene (400 mg/L). 
In mice exposed to either benzene (200 
mg/L), toluene (400 mg/L), or a mixture of ben-
zene (200 mg/L) + toluene (400 mg/L), increased 
levels of all selected neurotransmitters and their 
major metabolites were detected in all brain regions 
of every treatment group when compared to the 
untreated controls. In most cases statistically sig-
nificant increases of the major biogenic amines 
studied were more often found in the various brain 
region.'l analyzed than their metabolites (Tables 51, 
52,53 and 54). 
NE levels showed a significant increase in 
hypotbalamus and medulla oblongata in all 
treatment groups, cerebral cortex (benzene 200 
mg/L), midbrain (benzene 200 mg/L) and 
cerebellum (benzene 200 mgIL + toluene 400 
mg/L). Significant increases of DA concentra-
tions occurred in hypothalamus (benzene 200 mg/l, 
benzene 200 mg/L + toluene 400 mg/L), cerebral 
cortex (toluene 400 mg/L) and corpus striatum 
(benzene 200 mg/L). 
Significant increases of 5-HT levels were 
observed in bypothalamus in all treatment 
groups, cerebral cortex (benzene 200 mg/L, 
toluene 400 mg/L), medulla oblongata (benzene 
200 mg/L), corpus striatum (benzene 200 mg/L), 
and midbrain (benzene 200 mg/L, toluene 400 
mg/L). 
ConcommitantJy with the increases of these 
parent neurocbemicals, levels of each of their 
major metabolites also increased significantly in 
several brain regions. For example, there was a 
significant increase of VMA in medulla oblongata 
(toluene 400 mg/L, benzene 200 mg/L + toluene 
400 mg/L), DOPAC in corpus striatwn (benzene 
200 mgIL + toluene 400 mg/L), and HVA in 
hypothalamus (benzene 200 mgIL, benzene 200 
mg/L + toluene 400 mg/L), corpus striatum (ben-
zene 200 mg/L, benzene 200 mgIL + toluene 400 
mg/L), midbrain (benzene 200 mg/L) while the 
levels of 5-HIAA were found significantly 
increased in hypothalamus in all treatment. groups 
and in midbrain (benzene 200 mg/L, benzene 200 
mg/L + toluene 400 mg/L). 
When compared to the benzene (200 mg/L) or 
toluene (400 mg/L) only treatment groups, sig-
nificant differences in levels of selected neuro-
transmitters were not often found in the mixture 
(200 mg/L benzene + 400 mg/L toluene) treatment 
group in the present studies. However, levels of 
VMA were significantly different from those in 
benzene (200 mg/L) only treatment in medulla 
oblongata and in midbrain. DOPAC levels also 
sbowed significant differences from those in 
benzene (200 mg/L) only treatment in corpus 
striatum. 
Ne.yrotoxic Effects of Benzene (200 m gIL), 
Toluene (100 mglL), and aMixture of Benzene 
(200 mgIL) + Toluene (100 mglL) in Mice 
Benzene (200 mg/L), toluene (100 mg/L) and 
a mixture of benzene (200 mg/L) + toluene (100 
14 
mg/L) was continuously administered to adult CD-
I male mice via drinking water for 28 days, The 
catecholamines, indoleamine and their major 
metabolites in six brain regions were analyzed by 
HPLC to evaluate the neurotoxic effects. 
Similar to the exposure studies of benzene 
(200 mg/L) + toluene (400 mgIL), the mice 
exposed to either benzene (200 mg/L), toluene 
(100 mgIL) or a mixture of benzene (200 
mgIL) + toluene (100 mgIL) sbowed increased 
levels of brain biogenic amines and their major 
metabolites in an brain regions studied when 
compared to the untreated controls (Tables 55, 56, 
57, and 58). 
NE levels showed a significant increase in 
hypothalamus (toluene 100 mg/L), medulla 
oblongata (benzene 200 mg/L), corpus striatum 
(toluene 100 mg/L, benzene 200 mg/L + toluene 
100 mg/L) and midbrain (benzene 200 mgIL). 
Significant increases of DA were observed in 
hypothalamus (toluene 100 mg/L) and in corpus 
striatum (benzene 200 mg/L + toluene 100 
mgIL). The 5-HT levels in medulla oblongata 
(benzene 200 mgIL, toluene 100 mg/L) and in 
midbrain (benzene 200 mgIL) also increased 
significantly. 
The major metabolites of selected 
neurotransmitters increased in several brain 
regions: 5-mAA in hypothalamus (benzene 200 
mg/L), cerebral cortex (toluene 100 mg/L, 
benzene 200 mg/L + toluene 100 mgIL) and 
medulla oblongata (toluene 100 mg/L); DOPAC 
in cerebral cortex (toluene 100 mg/L), medulla 
oblongata (benzene 200 mg/L + toluene 100 
mg/L), and corpus striatum (toluene 100 mg/L, 
benzene 200 mgIL + toluene 100 mg/L); and 
HV A in cerebral cortex (toluene 100 mg/L, 
benzene 200 mg/L + toluene 100 mg/L), medulla 
oblongata (all treatment groups) and corpus 
striatum (all treatment groups). 
Significant differences between benzene or 
toluene treatment alone and the mixture exposure 
group. as with the results of interaction studies of 
benzene (200 mg/L) + toluene (400 mg/L), were 
not often detected. Only the concentration of 5-
HIAA in hypothalamus and HV A in corpus 
striatum of mixture group were found significant-
ly different from the benzene only treatment. 
The neurotoxic studie.~ of benzene and toluene 
interactions in CD-I mice have shown that neither 
a high dose of toluene (400 mgIL) nor a low dose 
of toluene (100 mg/L) significantly alters brain 
regional biogenic amines induced by benzene at 
200 mg/L. 
Swnmary and Conclusions 
Groundwater is an important source of drink-
ing water for approximately one-half of the U.S. 
population. Numerous underground storage tanks 
containing petroleum products may be leaking and 
contaminating public water supply wells across the 
U.S. Contamination of well water by petroleum 
products from LUST is a matter of great impor-
tance. LUST pose a serious threat to the ground-
water and public health. Many petroleum products 
are known or suspected carcinogens or mutagens 
which can cause adverse health effects. More 
research on the types and concentrations of petro-
leum products occurring in public drinking water 
well supplies, and the immunotoxic and neurotoxic 
effects of these organic compounds is needed. 
Wen water samples from five U. S. 
Geological Survey shallow monitoring wells and 
six deep drinking water wells in the vicinity of 
petroleum refineries, gasoline stations, or other 
activities (e.g., public works. steel manufacturing), 
were collected during this project (919/85 to 5n /87). The volatile or semivolatile organic com-
pounds detected in the shallow well water samples 
by GC or Ge/MS analysis varied in concentration, 
JJg/L (Tables 3 and 4). In addition to benzene, 
toluene, ethylbenzene, and 2.-xylene which are 
chemical constituents of gasoline, numerous other 
organic compounds were detected by GC/MS 
analysis (Table 5). 
Benzene, toluene, and phenol are major aro-
matic hydrocarbon compounds with environmental 
and occupational significance (Hsieh, 1988). The 
basic immunotoxic and neurotoxic effects of these 
chemicals were evaluated in this study by utilizing 
various imml1nological and neurological endocrine-
biochemical parameters in CD-l mice 
continuously exposed to nominal concentrations of 
O. 40, 200. and 1,000 mg/L benzene, 0, 20, 100, 
and 500 mg/L toluene and O. 5,20, and 100 mg/L 
phenol in drinking water for 4 weeks. The 
observed concentrations for benzene and toluene as 
determined by gas chromatography were 0, 31, 
166, and 790 mg/L, and 0, 17,80, and 405 mg/L, 
respectively. The observed concentrations for 
phenol were approximately 95 percent of the 
nominal concentrations (0, 4.75,19, and 95 mg/L) 
used. 
Benzene exposure caused a dose-dependent 
reduction in numbers of peripheral blood leuko-
cytes, lymphocytes, erythrocytes and resulted in a 
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severe macrocytic anemia. Splenic lymphocyte 
proliferation to both B cetJ and T cell mitogens 
(lipopolysaccharide, pokeweed mitogen, concana-
valin A, and phytohemagglutinin) was followed by 
a dose-related biphasic responsiveness, enhanced at 
the lowest dose (40 mgIL) and depressed in the 
higher dosage groups (200 and 1000 mg/L). Cell-
mediated immunity as measured by mixed-lympho-
cyte culture response to allogeneic cells and cyto-
toxic lymphocyte activity to YAC-I tumor cells 
exhibited similar biphasic phenomenon. Antibody 
production as assessed by enumeration of sheep red 
blood cell (SRBC)-specific plaque-forming cells 
(PFC) indicated a significant suppression of PPC 
in animals exposed to 200 and 1000 mg/L ben-
zene. A decrease in anti-SRBC antibody titer 
corresponded to the numbers of PFC. The findings 
indicate that oral ingestion of benzene produced a 
biologically significant alteration in both hwnoral 
and cellular immune responses. 
Benzene also induced both synthesis and cata-
bolism of regional brain monoamine neurotrans-
mitters. In the hypothalamus, the brain region 
richest in NE, concentrations of NE increased by 
·50, 58, and 61 percent when mice received doses of 
40, 200, and 1000 mg/L benzene, respectively. 
Significant increases of NE were also observed in 
the medulJa oblongata and cerebellum. Dopamine 
concentrations increased significantly in the 
hypothalamus and corpus striatwn. Increases of 
catecholamine metabolites were seen in a number 
of brain regions: midbrain (DOPAC), corpus stri-
atum (VMA, DOPAC, HV A), cerebral cortex 
(VMA) and cerebellum (VMA). Benzene treat-
ment significantly increased 5-Hf concentrations 
in the hypothalamus, corpus striatum, midbrain, 
cerebral cortex and medulla oblongata. Concom-
mitant with increases of 5-Hf, 5-IDAA increased 
in hypothalamus, corpus striatum, midbrain, cere-
bral cortex and medulla oblongata. 
Toluene is not as strong an immunotoxicant 
as its analogue benzene. No effects on hemato-
logical parameters, including erythrocytes, 
leukocytes and their differentials were noticed. 
Splenocyte lymphoproliferations to alloantigens 
decreased at the 500 mgIL toluene dose only. 
Numbers of SRBC-specific PFC decreased in the 
500 mg/L dosed animals, however, no significant 
change was observed in anti-SRBC antibody level. 
Toluene (500 mg/L) also adversely affected 1L- 2 
synthesis. It appeared that suppression of immune 
functions of mice ingesting toluene was generally 
evident at relatively high doses, except for splenic 
lymphocyte responses to selected mitogens, 
The maximum toluene-induced increases in 
brain biogenic amines and their metabolites 
occurred at a toluene concentration of 100 mg/L. In 
the hypothalamus, the concentrations of NE 
significantly increased by 51, 53, and 34 percent in 
groups dosed with 20, 100, and 500 mg/L toluene, 
respectively. Increases of NE were also observed 
in the medulla oblongata and midbrain. Corres-
pondingly, concentrations of VMA increased in 
various brain regions. 
Concentrations of DA were higher in the 
corpus striatum and hypothalamus. Alterations in 
levels of the DA metabolites, DOPAC and HV A, 
were marginal. Toluene increased 5-Hf in aU dis-
sected brain regions except cerebellum, and 5-
HIAA levels in the hypothalamus, corpus striatum 
and cerebral cortex. Noradrenergic and serotonergic 
neurons appeared to be highly vulnerable to 
toluene while dopaminergic neurons were rather 
resistant. 
The concentrations of hypothalamic NE and 
VMA, plasma ACTH and serum corticosterone 
were increased following both chemical exposures. 
Comparisons of benzene-treated mice with 
appropriate-time-controls revealed that corticoster-
one levels were significantly higher in mice after 7 
days (200 and 1000 mg/L benzene) and at 28 days 
(1000 mg/L of benzene). Toluene elevated corti-
costerone levels at 14 and 28 days at the 500 mg/L 
exposure. IL-2 production was suppressed in the 
two higher benzene-treated groups, while toluene 
decreased IL-2 synthesis at the 500 mg/L concen-
tration only. 
Results indicated that both benzene and 
toluene ingestion stimulated the hypothalamic-
pituitary-adrenocortical (HPA) axis, resulting in 
elevation of corticosterone which has been reported 
to inhibit IL-2 production and impair immuno-
competence. 
Phenol exposure, like the benzene exposure, 
caused a dose-dependent decrease in peripheral 
erythrocytes and leucocytes. Splenic lymphocyte 
proliferation to both B cell and T cell mitogens 
(LPS, PHA, Con A and PWM) also resulted in a 
significant suppression in the higher dosage groups 
(20 and 100 mg/L). Cell-mediated immunity as 
measured by mixed-lymphocyte culture response to 
allogeneic cells exhibited a biphasic response en-
hanced at the lowest dose (5 mg/L) and depressed in 
the higher dosage groups (20 and 100 mg/L). 
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Phenol depresses T-cell function in response to 
allogeneic cells. Antibody production as assessed 
by enumeration of sheep red blood cell (SRBC)-
specific antibody plaque-forming cells (PFC) 
showed a significant immunosuppression of PFC 
in animals exposed to 20 and 100 mg/L phenol. 
Phenol caused a dose-related decrease in 
regional brain monoamine neurotransmitters in 
several brain regions. The greatest effect of phenol 
on the major biogenic brain amines was in the 
hypothalamic region. NE showed a significant 
decrease at the two highest dose levels (20 and 100 
mg/L). Likewise, the indoleamine, 5-Hf, and its 
metabolite 5-HIAA were significantly decreased in 
the high exposure groups. 
In the corpus striatum, a brain region which 
is rich in DA, levels of this neurotransmitter were 
significantly decreased in all treatment groups as 
were 5-HT and VMA levels in the highest treat-
ment group (100 mg/L). Phenol exposure via 
drinking water can induce a decrease in the levels of 
selected neurotransmitters and the concentration 
alteration may be responsible for the reported 
encephalopathic effect of phenol exposure. 
The interactions of benzene and toluene were 
also evaluated in this study by utilizing various 
immunological and neuroendocrino-biochemical 
parameters in CD-1 mice continuously exposed to 
0, 40, 200, and 1000 mg/L benzene and 0, 20, 
100, and 500 mg/L toluene, respectively, in 
drinking water for 4 weeks. The toxicity of 
environmental pollutants such as benzene and 
toluene may be expressed as combined effects of 
the chemicals. Benzene frequently occurs in a co-
contaminated environment with toluene, a com-
petitive inhibitor of the biotransfonnation of 
benzene. When co-administered with benzene (200 
mg/L) , toluene (400 mg) completely inhibited 
benzene-induced immunotoxicity, i.e., involution 
of thymic mass and suppressions of both B- and T-
cell mitogeneses, mixed lymphocyte culture 
response to alloantigens, the ability of cytotoxic 
lymphocytes to lyse tumor cells, antibody produc-
tion respon~e to SRBC, and IL-2 secretion by Con 
A-stimulated mouse T-cells. However, the low 
dose oftoluene (100 mg/L) did not protect against 
benzene-induced depressions of immune function. 
The results demonstrate that toluene, in sufficient 
amounts, has an antagonistic effect on benzene 
immunotoxicity. When compared to the untreated 
controls, mice given the combined treatments of 
benzene and toluene exhibited elevated regional 
concentrations of brain amines and their metabo-
lites in several brain regions. Increased concentra-
tions of biogenic amine metabolites in a few brain 
regions were greater in the combined exposures of 
benzene and toluene than when either chemical was 
used alone; there was a marginal additive effect 
between these two types of neurotoxic ants. 
The present study demonstrates that benzene, 
toluene, and phenol possess the potential for 
inducing immunotoxic and neurotoxic effects in 
CD-I mice following 4 weeks of continuous expo-
sure via drinking water. Of particular importance 
was the fact that neurotoxic effects were evident 
at the lowest dose of benzene or toluene treatment, 
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and a no-effect level could not be established. 
Further studies involving lower levels of exposure 
of environmental pollutants are necessary to fully 
ascertain the safety of these compounds in drinking 
water. The results of combination studies suggest 
that benzene immunotoxicity is mainly due to 
action ofthe reactive metabolites, whereas benzene 
neurotoxicity results from benzene itself. In 
addition, both benzene and toluene have, at least 
partially, an additive negative effect on immune 
function via the activated HPA axis. 
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Application of Research Results 
Since this research project was approved and 
initiated on June 25, 1985, several agencies have 
expressed an interest in receiving data on the 
characterization and concentrations of organic 
chemicals detected in well water. The Davis 
County and South Salt Lake City Health 
Departments and the Bureau of Public Water 
Supplies, Division of Environmental Health, State 
of Utah Department of Health, would like to use 
the results to assist them in deveJopment of 
groundwater quality standards, to help pinpoint 
leaking underground storage tanks and to support 
efforts for protection of groundwater drinking water 
supplies and public health. Others who could 
make use of data produced by this project include 
the USGS, USEPA, Utah Bureau of Solid and 
Hazardous Waste, petroleum refining industries, 
and universities, among others. 
Although there is a large amount of infor-
mation available detailing the effects of benzene on 
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the hematopoietic system, studies concerning the 
immunotoxic evaluations of this chemical are 
scant. Also, little information is available 
regarding the effects of toluene exposure on im-
mune systems. In addition, despite several pub-
lished studies about the positive effects of benzene 
and toluene on behavioral changes, research 
conducted on the neurotoxic potential, (i.e., alter-
ations in brain neurochemicals), is still limited. 
little research has been done on the chronic effects 
of long-term exposure to trace levels of organic 
chemicals detected in drinking water (Varma et al., 
1976). The research results will provide toxi-
cologists and other researchers with more infor-
mation for better understanding the mechanisms 
and rates at which petroleum compounds impact 
human health, especially long-term health effects 
(i.e., immunotoxic and neurotoxic) of exposure to 
low levels of these organic compounds in drlnking 
water obtained from contaminated public well 
water supplies. 
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TABLE 1. Temperature, pH, and Conductance Values Of Well Water Collected from USGS Shallow 
Monitoring Wells During the September 9,1985 to April 24, 1987 Sampling Period. 
Shallow Well 
Water Samplest 
1985 
Sampling Dates 
1986 1987 
9·912·1012·16 12·17 2.6* 3·3 6·10 10·31 2·3 2·14 2·20 3·16 4·24 
Sample 1 
Temperitture(°C)tt 17.0 10.0 
pll· 7.8 7.8 
Conductance·'" 47175105 
(J.Ullhoslcm) 
Sample 2 
TemperatureeC)tt 18.0 
pH'" 7.0 
Conductance"'· 1546 
(f.UJlhos/cm) 
Sample 3 
Temperature(OC)tt 16.0 
pH'" 6.8 
Conductance"'''' 1339 
(f.UJlbos/cm ) 
Sample 4 
Temperature(°C)tt 
pH· 
Conductance"'· 
(pmhos/cm) 
Sample 5 
Temperatureec)tt 
pH· 
Conductance"'· 
(pmbos/cm) 
13.0 
6.6 
2306 
6.8 17.0 12.8 
6.6 7.8 7.4 
- 4104 
10.6 10.5 15.7 
6.6 6.9 6.9 
2277 
11.0 9.7 12.0 13.3 
7.4 6.5 6.6 6.9 
1662 1567 
13.9 10.4 
5.5 6.9 
16.7 10.4 8.5 
5.5 7.1 6.8 
10.0 10.6 
7.0 7.0 
10.7 
7.2 
11.6 
7.6··· 
16.0 
7.23 
t Well water sample number: Sample I collected at a private residence at 3138 N. 2450 W., North Salt 
Lake City, Utab; Sample 2 at a private residence at 5549 South Redwood Road near Murray~Utah; 
Sample 3 at the Sandy Public Works Dept. at 8775 S. 700 W., Sandy, Utah: Sample 4 at 7000 S. 
2000 E., Salt Lake City, Utah, just north of a Sinclair gas station; and, Sample 5 at the La Manns 
Apartments at 4500 S. 945 E., Salt Lake City, Utah. 
tt Temperature measured with a dry bulb tbennometer, or an Orion SA 250 meter . 
• pH measured with Hydrion paper or an Orion SA 250 meter 
• '" Conductance measured with YSI Model 33 S-C-T meter and corrected for condition at 250 C. 
• "'. Sediment masked color development. 
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TABLE 2. Temperature, pH. and Conductance Values Of Well Water Collected from Deep Wells During 
the November 8, 1985 to May 7, 1987 Sampling Period. 
Deep Well Sampling Dates 
Water Samplest 
1985 1986 1987 
11·8 2·1 2·2 2·6 5·31 6·1 6·5 6·10 4·24 5·7 
Sample 6 
Temperature(oC)tt 15.0 13.5 19.4 
pH· 6.6 6.5 6.7 
Conductance •• 
(J.lmhos/cm) 
Sample 7 
Temperature(°C)tt 15.6 13.4 19.2 
pH· 6.5 6.5 6.6 
Conductance •• 
(J.U11hos/cm) 
Sample 8 
Temperature(°C)tt 13.7 16.1 
pH· 6.5 6.6 
Conductance·· 
(J.1Illhos/ cm) 
Sample 9 
Temperature(°C)tt 12.8 14.4 17.2 
pH· 6.2 7.4 7.1 
Conductance·· 1127 
(Ilmhos/cm) 
Sample 10 
Temperature(°C)tt 13.6 14.2 17.0 
pH· 6.5 6.9 7.3 
Conductance·· 1179 
(Ilmhos/cm) 
Sample 11 
Temperature(°C)tt 16.7 19.4 
pH* 6.2 6.6 
Conductance·· 
(Ilmhos/cm) 
t Well water sample number: Sample 6 and 7 were collected at private residences at Pelican Point, Utah, 
west side of Utah Lake; Sample 8 at dairy farm, 17 Vineyard, S. of U.S. Steel··Geneva Works, 
Orem, Utah; Samples 9 and 10 from pasture west ofCrysen Oil Refinery, 2355 S. 1100 W., Woods 
Cross, Utah; and Sample 11 at a private residence at 3215 N. 2450 W., North Salt Lake City, Utah. 
ttTemperature measured with a dry bulb thermometer, or an Orion SA 250 meter. 
• pH measured with Hydrion paper or an Orion SA 250 meter . 
•• Conductance measured with YSI Model 33 S·C·T meter and corrected for condition at 25°C. 
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TABLE 3. Volatile Organic Compounds Detected by GC Analysis in Water Collected From Shallow Monitoring Wells Numer 1,2,3,4 and 5t. 
Compound 
Benzene 
Toulene 
Ethylbenzene 
p-Xylene 
1,3,5-Trimethylbenzene 
1,2,3,4-Tetramethylbenzene 
1,2,4,5-Tetramethylbenzene 
1-Methylnaphthalene 
Compound 
Benzene 
Toulene 
Ethylbenzene 
p-Xylene 
m-Xylene 
o-Xylene 
1,3,5-Trimethylbenzene 
1,2,3,4-Tetramethylbenzene 
1,2,4,5-Tetramethylbenzene 
I-Methylnaphthalene 
Naphthalene 
~ q fl! 
WeUNumber I 
9/9/85 9/9/85 
P&T MCE 
0.05 5.95 
9/9/85 9/9/85 2/6/86 2/6/86 
P&T MCE P&T MCE 
34.00 13.70 31.01 4.82 
4.19 1.87 
53.17 53.23 
7.79 0.48 
12.23 
5.83 
8.92 1.94 
9/9/85 
P&T 
COMPOUND CONCENTRATION (J.tgfL) 
WeUNumber2 
9/9/85 2/6/86 2/6/86 6/10/86 6/10/86 4/24/87 4/24/87 
MCE P&T MCE ~T MCE ~T MCE 
1.13 
9.57 
4.96 
COMPOUND CONCENTRATION (J.tgfL) 
WeU Number 3 
17.98 
0.32 
0.90 
6/10/86 6/10/87 2/3/87 2/3/87 2/20/87 2/20/87 3/16/87 3/16/87 5n/87 5n/87 
P&T MCE P&T MCE P&T MCE P&T MCE P&T MCE 
93.29 112.27 122.01 1.83 71.43 8.87 0.81 
8.67 23.47 4.01 8.70 
101.27 17.89 96.43 36.21 74.36 20.98 83.15 44.93 
25.26 26.99 13.67 
0.29 
0.31 2.58 
55.55 15.22 62.45 19.34 
7.03 8.90 9.49 
1.27 5.48 13.96 10.46 
5.18 4.14 
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TABLE 3. Volatile Organic Compounds Detected GC Analysis in Water Collected from Shallow Monitoring Wells Number 1,2,3,4 and 5t (cont.). 
Compound 
Benzene 
Toulene 
Ethylbenzene 
p-Xylene 
o-Xylene 
m-Xylene 
1,3,5-Trimethylbenzene 
1,2,3,4-Tetramethylbenzene 
1,2,4,5-Tetramethylbenzene 
1-Methylnaphthalene 
Naphthalene 
2/3/87 
P&T 
2/3/87 
MCE 
COMPOUND CONCENTRATION (p.g/L) 
Well Number 4 
2/14/87 2/14/87 3/16/87 3/16/87 
P&T MCE P&T MCE 
97.58 
57.70 
2.13 
6.50 
0.81 
2.49 
2.68 
2.66 
3.36 
18.23 
3.53 
Well Number 5 
2/14/87 2/14/87 
P&T MCE 
196.83 
122.33 
5.55 
14.54 
3.08 
8.36 
6.70 
6.90 
4.81 
t Well water sample number: Well number 1 water sample collected at a private residence at 3138 N. 2450 W., North Salt Lake City, Utah; Well number 2 
water sample collected at a private residence at 5549 South Redwood Road near Murray, Utah; Well number 3 water sample collected at the Sandy Public 
WOJ:k:s Dept. at 8775 S. 700 W., Sandy, Utah; Well number 4 water sample collected at 7000 S. 2000 E., Salt Lake City, Utah, just north of a Sinclair gas 
station; and Well number 5 water sample collected at the La Manns Apartments at 4500 S. 945 E., Salt Lake City, Utah. 
In 
NI 
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TABLE 4. Organic Compounds Quantified by GCIMS Analysis in Water Collected from Shallow Monitoring Wells Number 3 and 4. 
COMPOUND CONCENTRATION (p.g/L) 
Well Number 3 
213/87 213/87 2/20/87 3/16/87 3/16/87 5n/87 5n/87 
Compound MCE MCE MCE MCE MCE P&T P&T 
1,2,3,4-Tetramethylbemene 11.58 12.68 29.84 
1,2,3,5-Tetramethylbemene 15.32 16.91 
1,2,3-Trimethylbemene 5.78 
1,2,4-Trimethylbemene 15.45 
l-Ethyl-2-methylbemene 3.67 6.26 0.33 
l-Ethyl-4-methylbemene 0.33 
l-Ethylnaphthalene 0.01 
I-Methylnaphthalene 2.31 3.28 4.58 
2,3-Dihydro-1H-indene 1.79 45.01 39.73 42.23 1.20 1.47 
Benzene 119.5 34.86 
Diethylbemene 0.06 0.48 0.58 5.13 
Ethylbemene 10.69 12.37 161.70 273.70 21.63 1.19 
Ethylmethylbenzene 56.24 43.21 39.89 
Naphthalene 13.61 16.43 8.20 
Propylbenzene 0.12 0.13 1.04 1.40 1.05 0.01 0.11 
Toluene 2.89 3.56 0.38 
Trlmethylbenzene 51.69 55.02 494.40 676.10 738.80 . 
Xylene 33.12 1.02 
Well Number 4 
213/87 
MCE 
1.87 
0.83 
t Well water sample number: Well number 3 water sample collected at the Sandy Public Works Dpt. at 8775 S. 700 W., Sandy, Utah; and Well number 4 
water sample collected at 7000 S. 2000 E., Salt Lake City. Utah, just north of a Sinclair gas station. 
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TABLE 5. Compounds Detected by GC/MS analysis of Shallow Monitoring Well Water Samples 
AnaJyzed in tbe Study. 
Purge and Trap 
( I-Metbyletbyl)benzene 
1,1,1 -Trichloroetbane 
1,2,3,4-TetrabydronaphtbaJene 
1,2,3,4-Tetrametbylbenzene 
1,2,3,5-Tetrametbylbenzene 
1,2,3-Trimetbylbenzene 
1,2,4-Trimetbylbenzene 
I,3-DiethylbeD7.ene 
I-Ethyl-2-metbylbenzene 
I-Etbyl-4-(I-metbylethyl)benzene 
l-Etbyl-4-metbylbenzene 
I-Etbylidene-IH-indene 
I-EtbylnaphtbaJene 
1-Metbyl-2-propyl-benzene 
I-Methyl-4-(I-metbyletbyl)benzene 
1-Metby 1-4-propylbenzene 
I-MetbyloaphthaJene 
I-Pentylcyclohexane 
2,3-Dibydro-I ,3-dimethyl-IH-indene 
2,3-Dibydro-l-metbyl-IH-indene 
2,3-Dibydro-IH-indene 
2,3-Dibydro-4,6-dimetbyl-IH-indene 
2-Chloro-I-phenylethanone 
2-Ethy 1-1 .3-dimetbylbenzene 
2-Etbyl-I,4-dimethylbenzene 
3,4-Dimethyl-I-hexane 
5-Methyl,(Z)-4-undecene 
Benzaldehyde 
Benzene 
Dichlorometbane . 
Diethylbenzene 
Etbylbenzene 
Metbylenepropanedinitrile 
NaphtbaJene 
Oxybis[ dichloro ]methane 
Propylbenzene 
Toluene 
Trichlorometbane 
Xylene 
Extraction/Concentration Metbods 
30 
Metbylene Chloride Extract 
(I,I-Dimethyl-2-propenyl)benzene 
(2-Metbyl-2-propenyl)benzene 
(2-Propenyloxy )-benzene 
1,3,5-Trimetbylbenzene 
1-Etbenyl-2-metbylbenzene 
l-Etbenyl-3,5-dimetbylbenzene 
I-Etbenyl-3-etbylbenzene 
I-Metbyl-2-(2-propenyl)benzene 
I-MetbyloaphtbaJene 
1-Etby 1-2-metbylbenzene 
IH-Imidizole-2-carboxaldehyde 
2-Chlorocyclobexanol 
2,3-Dibydro-I,I,3-trimethyl-3-phenyl-IH-indene 
2,3-Dibydro-l-metbyl-l H-indene 
2,3-Dibydro-IH-indene-I-one 
2.3-Dibydro-IH-indene 
2,3-Dibydro-2-methyl-IH-indene 
2-Etbyl-I ,4-dimethylbenzene 
2-[ (phenylmethyl)amino ]etbanol 
3-Metbylundecene 
Benzo[B ]tbiophene 
Bis(2-etbylhexyl)phtbalate 
DibutylphtbaJate 
Dietbylbenzene 
Dimetbylethylbenzene 
Etbylbenzene 
Etbylmetbylbenzene 
Iso-propyJbenzene 
Metbylpropylbenzene 
Metbylundecene 
NaphtbaJene 
Propylbenzene 
Sulfur dioxide 
Sulfur 
Tetrametbylbenzene 
Toluene 
Trimetbylbenzene 
Xylene 
TABLE 6. Effect of Benzene Exposure on Body Weight Gain 
Concentration in water/mg/l 
Dose Body Weight Gain 
Nominal Observed (mg/kglday) (gm)a 
0 0 0 7.82± 0.91a 
(control) 
40 31 8 7.26 ± 1.68 
200 166 40 9.04 ± 1.10 
1000 790 180 9.12 ± 1.66 
aValues are given as mean ± S.D. (n=5). 
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TABLE 7. Organ and Body Weight of CD-I Mice Following 4 Weeks of Benzene Exposurea 
Concentration in water (mg/L) Body Weight (g)b 
Doses 
Nominal Observed mglkg/day Day 0 Day 28 
0 0 0 23.20±O.37 31.22±O.62 
40 31 8 22.68±O.33 29.94±O.98 
200 166 40 23.74±O.22 32.98±O.65 
1000 790 180 23.14±O.29 32.26±O.86 
~enzene was administered continuously via drinking water for four weeks. 
bvalues are given as mean ± S.B. (n = 5). 
*Significantly (p < 0.05) different from control (0 mg/L) values. 
11! 
Spleen 
0.33±0.02 
0.30±0.01 
0.28±O.01 
0.26±O.01* 
Organ weight (g/lOOg body weight)b 
Liver Kidney Tbymus 
5.57±0.13 1.55±0.06 0.16±O.02 
5.46±0.29 1.58±0.08 0.12±O.0l 
5.86±O.70 1.65±0.10 0.12±0.0l 
S.98±O.20 1.87±O.05* 0.11±0.0l 
TABLE 8. Effect of Benzene Exposure on Spleen Cellularity and Selected Blood Parametersa• 
Leukocyte absolute differentials 
Dose· Spleen Cell No. Erythrocytes Hematocrit MCV** Leukocytes 
(mg/L) (dO·') (l0·6/mm3) (%) (tl) (10-3jmm3) Lymphocytes Neutrophils OIhers*** 
(l0·2jmm3) (10-2/mm3) (l0-2jmm3) 
0 7.5I±O.40 7.01±O.65 50.30±0.58 74.01±6.03 5.96±0.60 43.75±5.23 1O.97±1.33 4.49±0.78 
40 7.91±O.62 4.57±O.28b 48.80±0.46 108.30± 6.49b 4.23±0.07b 29.94±O.70b 8.49±1.03 3.77±0.54 
\,j..l 
\,j..l 
200 7.50±0.41 3.68±O.65b 46.20±0.46b 125. 18±15.68b 4.22±0.57b 23.48±3.04b 14.60±2.42 3.97±0.92 
1000 5.17±O.64b 3.43±O.39b 45.00±1.22b 136.76±12.57b 2.87±0.16b 16.06±2.02b 10.16±O.74 2.47±0.93 
a Values are given as mean ± S.E. (n = 5). 
b Significantly (p < 0.05) different from control (0 mg/L) values. 
* Benzene was administered continuously to CD-I mice in drinking water for 4 weeks. 
**Mean corpuscular volume. 
***Including monocytes, eosinophils and basopbils., 
TABLE 9. Effect of Benzene Exposure on Splenic Lymphocyte Proliferative Response to Mitogens. 
Mitogenic responses·· 
Dose* 
(mg/L) None LPS PWM ConA PHA 
0 1.68±0.31a 102.04±23.66 7.45±1.90 154.69± 49.33 68.02±18.57 
40 3.55±0.89b 261.23±25.62b 12.92±2.19b 384.90±1 08.61 b 258.81±88.01 b 
200 1.13±0.13 22.43±3.48b 3.25±O.71 29.30± 7.69b 16.43±3.94b 
1000 0.91±0.19 25.44±6.20b 3.65±O.72 14.61± 2.66b 8.87±1.83b 
* Benzene was administered continuously to CD-I mice in drinking water for 4 weeks. 
** dpm/106 splenic cells (xlO-3): response evaluated by incorporation of [methyl-3H]-thymidine into day 2 
splenocyte cultures for 6 hours pulsing. 
a Values are given as mean ± S.E. (n=5). 
b Significantly (p<0.05) different from control (0 mg/L) values. 
TABLE 10. Effect of Benzene Exposure on Mixed Lymphocyte Response. 
DPM/l06 cells (xl 0-3) ** 
Doses· 
(mg/L) Responders Responders + Simulators 
0 2.77±O.30 31.49±2.77 
(Control) 
40 3.59±0.87 56.24±1.59a 
200 1.71±O.42 18.77±2.36a 
1000 1.58±0.18 9.30±O.88a 
* Ben7.ene was administered continuously to CD-I mice via drinking water for 4 weeks. 
** Responder cells were the syngeneic splenic cells of CD-I mice and stimulator cells were the allogeneic 
Yac-l cells. A ratio of two stimulators to one responder was used, and the stimulator cells were treated 
with mitomycin-C before addition to the culture. MLC evaluated by incorporation of [methyl-3H] -
thymidine into day 3 MLC cultures for 6 hours pUlsing. Values are given as mean ±S.E. (n = 5). 
a Significantly (p < 0.05) different from control (0 mg/L) values. 
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TABLE 11. Effect of Benzene Exposure on Cytotoxic T-Lymphocytes (CIL) Response. 
% Cytotoxicitya 
Dose* 
(mg/L) 50:1** 25:1 
0 15.72±1.16 15.98±2.98 
(Conttol) 
40 17.94±1.61 23.32±2.05b 
200 8.77±L87b 11.09±1.71 
1000 5.82±O.94b 9. 17±1.53b 
* Benzene was administered continuously to CD-I mice in drinking water for 4 weeks. 
** Effector (day 5 MLC lymphocytes) -to - target (51Cr labelled Yac-l cells) cell ratio. 
a Values are given as mean ± S.E. (n = 5). 
b Significantly (p <0.05) different from control (0 mg/L) values. 
TABLE 12. Effect of Benzene Exposure on the Antibody Responses to Thymic-Dependent Antigen Sheep 
,.. 
Erythrocyte (SRBC) . 
Dose 
,..,.. 
Spleen cell No PFC/106 PFC/totalSpleen cells a-SRBC 
(ms'Kglday) (xlO~ Splenic cells (x10~ Antibody.Titer 
0 22.59±3.02 1.254±17a 295.72±74.5l 0.44±O.06 
8 16.80±1.59a 1.576±65 268.80±36.10 0.57±O.11 
40 ·15.36±0.65a 643±49a 99.76±10.32a 0.31±Q.05 
180 l2.70±1.51a 229±40a 31.4l± 9.52a 0.21±0.0Ia 
* Mice were sensitized with SRBC 4 days before the end of the benzene exposure. Splenic lymphocytes 
were analyzed for antibody forming cells (plaque-fonning cell, PFC) and sera were detected for antibody 
titer (a-SRBC) detennined in sera. Values are given as mean ± S.E. (n = 5). 
** Benzene was administered continuously to CD-I mice in drinking water for four weeks. 
a Significantly (p < 0.05) different from conttol (0 mg/L) values. 
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TABLE 13. Effect of Benzene on Regional Brain Catecholamines *. 
Brain Regiona 
Dosesc 
Catecholamineb (mg/L) Hypothalamus MeduUa Oblongata CerebeUum 
1000 1.63±0.lS* O.71±O.Ol 0.38±O.03* 
200 1.60±0.22* 0.78±O.03* 0.33±O.02 
NE 40 1.27±0.11 0.69±O.OS O.29±O.03 
0 O.96±0.08 0.61±O.03 0.26±O.OS 
1000 0.4O±0.03 O.24±O.Ol 0.28±O.01* 
VMA 200 0.37±0.OS O.24±O.Ol 0.23±O.01* 
40 0.30±0.04 0.24±O.01 0.24±O.02* 
0 0.26±0.02 0.19±O.03 0.19±O.01 
1000 0.4S±O.OS 0.04±O.00 0.03±O.01 
DA 200 0.49±O.11 O.OS±O.Ol 0.03±O.01 
40 O.41±O.OS 0.08±O.02 0.04±O.02 
0 0.30±0.OS O.OS±O.Ol O.04±O.Ol 
1000 0.13±0.02 0.07±O.00 0.07±O.01 
DOPAC 200 0.16±0.02* 0.08±O.01* O.O6±O.Ol 
40 0.08±0.01 0.08±O.01* O.OS±O.Ol 
0 0.10±0.02 O.OS±O.Ol 0.04±0.01 
1000 0.07±0.03 O.OS±O.OO 0.03±0.00 
HVA 200 0.1l±0.02 0.06±O.01 0.03±O.00 
40 0.13±0.02 0.07±O.01 0.OS±0.02 
0 0.09±O.03 O.OS±O.Ol 0.02±0.01 
a Ilg brain biogenic amines/g wet tissue (mean ± S.E.) 
b NE: Norepinephrine; VMA: Vanillylmandelic acid; DA: dopamine; DOPAC: dihydroxyphenylacetic 
acid; HV A: homovaniUic acid. 
C Doses were administered continuously to CD-I mice in drinking water daily for 4 weeks. 
* Significantly (p < O.OS) different from control (O mg/L) values. 
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TABLE 14. Effect of Benzene on Regional Brnin Catecholamines. 
Brnin Region8 
Dosesc 
Catecholamine (mg/L) Midbrain Corpus Stradum Cortex 
1000 0.72±0.03* 0.34±O.04 0.S2±O.02 
200 0.62±O.03* 0.36±O.03 O.72±O.OS* 
NE 40 0.6S±O.02* 0.27±O.02 0.S3±0.20 
0 0.4S±O.OS 0.33±O.07 0.34±0.OS 
1000 O.27±O.03 0.30±O.04* 0.29±0.01* 
VMA 200 0.2S±O.02 0.29±O.01* 0.3S±0.04* 
40 0.29±O.02 0.2S±O.03* 0.28±O.03* 
0 0.23±O.O3 0.20±O.03 0.17±0.02 
1000 0.25±0.OL S.88±O.66 1.1l±0.06 
DA 200 0.21±O.02 S.IS±O.72 1.64±0.23 
40 0.23±0.03 7.2S±O.35 1.62±O.44 
0 0.19±O.01 6.S9±O.Sl 0.87±O.09 
1000 0.15±O.01* 1.04±O.09* 0.2J±0.01 
DOPAC 200 0.15±O.01 * 0.S4±O.06 0.30±0.03* 
40 O.lS±O.Ol* 0.7J±O.02 0.2S±O.05* 
0 0.11±0.01 0.71±O.09 0.14±O.02 
1000 O.lS±O.Ol* 1.04±O.10* 0.22±O.01 
HVA 200 0.14±O.01* 0.97±O.09 0.30±0.04* 
40 0.19±O.01* 0.S7±O.06 0.29±O.06* 
0 O.l1±O.Ol 0.73±O.OS 0.14±0.01 
8 J1g brain biogeoic amines/g wet dssue (mean ± S.B.). 
b NE: norepineptuine; VMA: Vaoillylmaodelic acid; DA: dopamine; DOPAC: dihydroxyphenylacedc 
acid; HV A: homovanillic acid. 
C Doses were administered condouously to CD-I mice in drinking water daily for 4 weeks. 
* Significantly (p < 0.05) different from control (0 mg/L) values. 
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TABLE 15. Effect of Benzene on Regional Brain Indoleamines. 
Brain Region8 
Dosesc 
Indoleamineb (mgIL) Hypothalamus Medulla Oblongata 
1000 0.SI±0.12 0.S4±O.03 
S-Hf 200 1.03±0.IS 0.S2±0.03 
40 0.SS±0.12 0.94±0.OS* 
0 O.63±O.1O 0.76±O.OS 
(Control) 
1000 0.44±0.09 0.34±0.02 
S-HIAA 200 0.40±0.07 0.29±O.O2 
40 O.4S±O.10 O.3S±O.02 
0 O.26±O.03 0.30±O.02 
(Control) 
a Ilg brain biogenic amines/g wet tissue (mean ± S.E.). 
b S-Hf: S-hydroxytryptamine (serotonin); S-HIAA: S-hydroxyindoleacetic acid. 
c Doses were administered in drinking water daily for 4 weeks. 
* Significantly (p < O.OS) different from control (0 mgIL) values. 
TABLE 16. Effect of Benzene on Regional Brain Indoleamines. 
Brain Region8 
Dosesc 
Indoleamineb (mgIL) Midbrain COIpUS Stratium 
1000 1.07±0.02* 0.70±0.06 
S-Hf 200 1.04±0.03* 0.80±O.O3 
40 1.0S±O.06* 0.70±0.04 
0 0.Sl±0.08 0.61±O.OS 
(Control) 
1000 0.52±O.02* 0.39±0.03 
S-HIAA 200 0.40±0.01* 0.40±0.02 
40 0.Sl±O.03* 0.32±0.03 
0 0.33±O.03 0.30±0.OS 
(Control) 
8 Ilg brain biogenic amines/g wet tissue (mean ± S.B.). 
b S-Hf: S-hydroxytryptamine (serotonin); S-HIAA: S-hydroxyindoleacetic acid. 
C Doses were administered in drinking water daily for 4 weeks. 
* Significantly (p < O.OS) different from control (0 mgIL) values. 
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Cerebellum 
0.31±O.O4 
0.23±O.02 
0.27±O.03 
0.23±O.03 
0.J2±O.02 
O.OS±O.OO 
0.10±O.02 
0.09±O.01 
Cortex 
0.89±0.OS 
1.31±O.17* 
1.34±O.2S* 
0.S7±0.06 
0.26±0.02* 
0.31±0.04* 
0.33±0.OS* 
0.14±O.02 
TABLE 17. Effect of Toluene Exposure on Body Weight Gain in CD-I Mice. 
Concentration in water, mg/L 
Dose Body Weight Gain 
Nonninal ObselVed (mg,'kg/day) (gm)a 
0 0 0 14.24 ± 2.52 
(Control) 
20 17 5 13.70 ± 1.42 
100 80 22 13.02 ± 1.05 
500 405 105 15.14 ± 1.59 
a Values are given as mean ± S.D. (n = 5). 
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TABLE 18. Organ and Body Weight of Mice Following Toluene Exposure 
Body Weight (g)b 
Dosea 
(mg/L) Day 0 Day 28 Spleen 
0 20.62±O.13 34.86:H.18 0.34±0.03 
20 20.56±O.02 34.26±0.64 0.31±0.01 
100 20.16±O.31 33. 18±O.21 0.33±O.01 
500 20.00±0.23 35. 12±O.72 0.28±O.01 
a Toluene was administered continuously to CD-I mice in drinking water for 4 weeks. 
b Values are given as mean ± S.B. (n = 5) . 
... Significantly different from control values at p < 0.05. 
III 
Organ Weight (g/100 g body weight)b 
Liver Kidney Thymus 
5.67±O.07 1. 62±0. 05 0.19±O.02 
6.09±O.17 1. 72±0. 06 0.18±O.01 
6.32±O.17 1.68±O.03 0.18±O.02 
6. 73±0. 14* 1. 68±O.05 0.13±0.02* 
.t:. 
-
TABLE 19. Effect of Toluene Exposure on Spleen Cellularity and Selected Blood Parametersa. 
Doseh 
(mg/L) 
o 
20 
100 
500 
Total 
Splenocyte 
(x 10-7) 
7.71±0.27C 
6. 18±O.52 
6.57±O.91 
6.58±0.47 
Erythrocyte 
(106/mm3) 
9.30±0.26 
9.87±O.49 
8.79±O.85 
9.38±O.38 
a Values are given as mean ± S.E. (n = 5). 
Leukocyte 
(103/mm3) 
5.96±l.02 
6.34±O.57 
6.43±O.57 
3.90±O.36 
b Toluene was administered continously to CD-I mice in drinking water for 4 weeks. 
c Including monocytes, eosinopbils and basophils • 
. , 
Lymphocyte 
(103/mm3) 
4.40±0.62 
4.46±O.38 
4.50±0.78 
2.81±0.32 
Leukocyte absolute differentials 
Neutrophil 
(l03/mm3) 
1.13±O.38 
1.46±O.39 
I.42±O.48 
O.82±O.I6 
Othef 
(l03/mm3) 
O.4I±0.08 
0.42±O.09 
O.50±O.07 
0.36±0.05 
TABLE 20. Effect of Toluene Exposure on Splenic Lymphocyte Proliferative Response to Mitogens. 
Mitogenic responses** 
Dose* 
(mg/L) None LPS PWM ConA PHA 
0 4.3O±L86 369.88±76.57 28.98±13.23 707.93±170.38 141.62± 2.92 
20 1.80±0.81a 228.33±133.25 9.76± 5.75a 268.67±234.72 59.01±42.67 
100 1.82±O.89a 182.70± 52.44a 7.79± 3.87R 143.43±l09.34a 43.31±22.48 
b 
500 1.41±O.52a 170.33± 67.67a 7.34± 1.37a 179.04±l05.21a 39. 97±24.05a 
'" Toluene was administered continuously to CD-l mice in drinking water for 4 weeks . 
•• dpm/2xl06 splenic cells (xlO-3): response evaluated by incorporation of [methyl- 3a] -thymidine into 
day 2 splenocyte cultures for 6 hours pulsing. Values are given as mean ± S.D. (n = 5). 
a Significantly (p < 0.05) different from control (0 mg/L) values. 
TABLE 21. Effect of Toluene Exposure on Mixed Lymphocyte Response. 
DPM/106 cells (xlO-3)** 
Dose * 
(mg/L) Responders Responders + Stimulators 
0 5.20±0.67 28.99± 9.30 
20 4.62±O.92 29.18±11.26 
100 4.72±2.20 23.30± 7.80 
500 2.47±O.42a 14.87± 4.79a 
* * Responder cells were the syngeneic splenic cells of CD-I mice and stimulator cells were the allogeneic 
Yac-! ceUs. A ratio of two stimulators to one responder was used, and the stimulator cells were treated 
with mitomycin-C before addition to the culture. MLC evaluated by incorporation of [methyl-3H] -
thymidine into day 3 MLC cultures for 6 hours pulsing. Values are given as mean ± S.D. (n = 5). 
* Toluene was administered continuously to CD-l mice in drinking water for 4 weeks. 
a Significantly (p < 0.05) different from control (0 mg/L) values. 
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TABLE 22. Effect of Toluene Exposure on Cytotoxic T-Lympbocytes (en.) Response. 
Dose 
(mgIL) 50:1b 
0 13.74±1.47b 
20 12.09±O.75 
100 11. 19±O.82 
500 8.67±1.60* 
a Values are given as mean ± S.D. (n = 5). 
b Effector-to-target cell ratio. 
%Cytotoxicitya 
'" Significantly (p < 0.05) different from control (0 mgIL) values. 
25:1 
16.49±7.45 
13.29±2.47 
12.34±1.31 
10.30±1.40 
TABLE 23. Effect of Toluene Exposure on Antibody Plaque Forming Cells (PFC) and Antibody Titer (a.-
SRBC)'" 
Dose** Total Splenocytes PFC/106 PFCrrotal a.-SRBC 
(mg/kg/day) (dO·7) Splenocytes Spleen Cells Antibody Titer 
0 20. 16±2.75 1,184± 90 238,545±37,429 0.44±0.04 
5 16.68±1.19 985±105 166,015±30,231 0.55±0.06 
22 21.78±3.05 973±116 217,891±47,845 0.43±O.05 
105 13.66±1.79 631£278 89,936±13,26~ 0.32±O.03 
'" Mice were sensitized with thymic-dependent antigen sheep erythrocyte (SRBC) four days before the end 
of toluene exposure. Splenocytes were analyzed for antibody plague forming cell and antibody titer (a.-
SRBC) determined in Sera. Values are given as mean ± S.E. (n = 5). 
"'* Toluene was administered continuously to CD-I mice in drinking water for four weeks. 
a Significantly (p < 0.05) different from control (0 mgIL) values. 
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TABLE 24. Effect of Toluene On Regional Brain Catecholamines 
Brain Regiona 
Dosec Medulla 
Catecbolamineb (mg/L) Hypothalamus Oblongata Cerebellum 
SOO 1.76±0.30* 0.78±0.07 0.38±0.O4 
100 2.13±0.37* 0.9S±0.21* 0.42±0.OS 
NE 20 1.98±0.OS* 0.70±0.10 0.34±0.03 
0 1.31±0.lS 0.66±0.O6 0.33±0.09 
SOO 0.60±0.47 O.30±0.04 0.24±0.02 
VMA 100 0.39±O.10 0.36±0.09* O.27±0.04 
20 0.42±0.O3 0.30±0.03 0.29±O.02 
0 0.24±O.04 O.2S±O.01 0.2S±O.03 
) 
SOO O.13±O.OS 0.03±0.01 0.O3±0.01 
DOPAC 100 0.23±0.OS* 0.07±0.02* 0.O3±0.01 
20 0.18±0.03* 0.04±O.01 0.02±0.00 
0 0.09±0.O2 0.04±0.02 O.03±O.01 
SOO 0.68±0.21* 0.10±0.02 O.OS±O.Ol 
DA 100 0.74±0.19* 0.10±0.04 0.04±O.02 
20 0.66±0.14* 0.07±0.03 0.04±0.01 
0 0.40±0.10 0.10±0.01 0.04±0.01 
SOO 0.U±O.16 0.03±0.04 O.02±0.02* 
HVA 100 0.22±O.06 O.l0±0.OS O.O4±O.01 
20 0.09±0.13 0.03±O.O2 O.O1±0.02 
0 O.ll±O.l1 0.06±O.O2 0.01±0.02 
a I.tg: brain biogenic amines/g wet brain tissue (means ± S.D., n = S). 
b NE: norepinephrine, VMA: Vanillylmandelic acid, DOPAC: dihydroxyphenylacetic acid, DA: 
dopamine, HV A: homovanillic acid. 
C Doses were administered continously to CD-l mice in drinking water for 4 weeks. 
* Significantly (p < O.OS) different from control (0 mg/L) values. 
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TABLE 2S. Effect of Benzene on Regional Brain Catecholamines 
Brain Regiona 
Dosec Cotpus 
Catecholamineb (mg/L) Midbrain Striatum Cortex 
SOO 0.69±O.04* 0.36±0.11 0.43±0.OS 
100 0.67±o.06* 0.3S±0.03 0.46±0.06 
NE 20 0.66±O.07* 0.37±0.09 0.41±0.06 
0 0.S8±O.03 0.32±0.10 0.36±0.04 
SOO 0.38±O.02* 0.S7±0.07* 0.3S±0.01* 
VMA 100 0.36±o.03* 0.41±O.04* 0.2S±O.03 
20 0.32±O.02 0.32±0.04 0.27±O.01 
0 0.30±O.OS 0.3l±O.02 0.2S±0.04 
SOO 0.12±O.O2 1.39±0.17 0.18±0.03 
DOPAC 100 0.13±O.O4 1.06±0.12 0.19±0.03 
20 0.19±O.1l 1.06±0.47 0.16±0.04 
0 0.14±O.02 1.06±0.46 0.19±O.02 
SOO 0.39±O.14 11.6S±1.1l* 1.13±O.19 
DA 100 0.3l±O.09 8.28±1.07* 1.24±O.36 
20 0.78±O.68 7.34±2.09 1.12±0.29 
0 0.27±O.06 6.41±O.76 1. 20±0. 2 1 
SOO 0.13±O.02 1.24±O.17* 0.17±0.04 
HVA 100 0.12±O.02 0.9S±0.14 0.18±0.OS 
20 0.16±O.07 0.79±0.3S 0.14±O.03 
0 0.13±O.OS 0.83±0.20 0.18±0.04 
a J.1g: brain biogenic amines/g wet brain tissue (mean ± S.D., n = S). 
b NE: norepinephrine, VMA: Vanillylmandelic acid, DOPAC: dihydroxyphenylacetic acid, DA: 
dopamine, HV A: homovanillic acid. 
C Doxes were administered continuously to CD-I mice in drinking water for 4 weeks. 
* Significantly (p < O.OS) different from control (0 mg/L) values. 
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TABLE 26. Effect of Toluene on Regional Brain Indoleamines. 
Brain Regiona 
Dosesc Medulla 
Indoleamineb (mgIL) Hypothalamus Oblongata Cerebellum 
500 1.00±0.26 0.90±0.10* 0.19±0.06 
5·HT 100 1.44±O.43* 1.07±0.15* 0.27±O.06 
20 0.94±O.20 0.79±0.07 0.19±0.06 
0 0.70±0.16 0.76±O.05 0.22±0.12 
500 0.49±0.17 0.31±0.07 0.06±0.01 
5·1DAA 100 0.86±O.28* 0.43±O.IO* 0.11±0.04 
20 0.65±0.15 0.33±0.04 0.08±0.03 
0 0.37±0.07 0.32±0.03 0.09±0.05 
a p,g: brain biogenic amioes/g wet brain tissue (mean ± S.D., n ::.. 5). 
b 5-HT: 5-hydroxytryptamine (serotonin), 5·1DAA: 5-hydroxyindoleacetic acid. 
C Doses were administered continuously to CD-I mice in drinking water daily for 4 weeks. 
* Significantly (p < 0.05) different from control (0 mgIL) values. 
TABLE 27. Effect of Toluene on Regional Brain Indoleamines 
Brain Regiona 
Dosesc Corpus 
Indoleamineb (mgIL) Midbrain Striatum 
500 0.9S±O.04* O.72±O.OS* 
5-HT 100 1.10±O.16* 0.76±0.09* 
20 1.02±1.10* 0.64±0.11 
0 0.76±O.04 0.53±0.OS 
500 0.32±O.02 0.40±0.07 
5-1DAA 100 0.42±O.14 0.42±OJ}3 
20 0.42±O.05 0.39±0.OS 
0 0.37±O.01 0.35±0.06 
a p,g: brain biogenic amines/g wet brain tissue (mean ± S.D., n ::.. 5). 
b 5-HT: 5-hydroxytryptamine (serotonin), 5-1DAA: 5-hydroxyindoleacetic acid. 
c Doses were administered in drinking water daily for 4 weeks. 
* Significantly (p < 0.05) different from control (0 mgIL) values. 
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Cortex 
0.65±0.01* 
0.79±0.11 * 
0.66±O.02* 
0.53±0.03 
0.lS±0.02 
0.23±0.06* 
0.19±0.03 
0.17±0.02 
TABLE 28. Effect of Phenol Exposure on Body Weight Gain in CD-l Mice. 
Concentration in water, mg/L a 
Dose Body Weight Gain 
Nominal Observed (mg/kwday) (gm)b 
0 0 0 9.58 ± 1.04 
(Control) 
5 4.75 1.36 10.26 ± 1.46 
20 19.0 5.35 9.78 ± 2.03 
100 95.0 26.55 10.92 ± 1.84 
a The observed concentrations for phenol were approximately 95 percent of the nominal concentrations. 
bValues are given as mean ± S.D. (n:= 5). 
TABLE 29. Organ and Body Weight of CD-1 Mice Following Phenol Exposure. 
Organ Weight Relative to Body Weight (gm/lOOgm)b 
Dosea BodyWeigbt 
(mg/L) (gm) Spleen Uver Kidney 
0 33.66±1.23 0.35±O.04 6.48±O.59 1.56±O.20 
5 33.54±1.57 0.32±O.07 6.25±O.44 1.76±O.11 
20 33.68±1.73 0.33±0.04 6.lO±O.79 1.68±O.19 
100 34.86±2.20 0.29±O.03 6.01±0.07 1.71±O.25 
a Phenol was administered continuously to CD-1 mice in drinking water for four weeks. 
bvalues are given as mean ± S.D. (0 = 5). 
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Thymus 
0.15±0.Ol 
0.14±O.04 
0.14±O.03 
0.12#>.02 
TABLE 30. Effect of Phenol Exposure on Spleen Cellularity and Selected Blood Parametersa. 
Doseb 
C C d 
Total spleen WBC RBC PCV Expressed as % ofWBC's 
(mgIL) Cellularity (xlO-3) (xlO-3) % 
(xl 0-7) Lymphocytes Neutrophils 
0 8.59±0.75 6.06±0.38 7. 17±1.24 48.00±1.17 74.20±4.09 17.0o±2.24 
5 7.94±0.44 5.82±1.34 4.90±1.20* 49.10±1.52 71.80±4.60 19.4o±1.67 
20 7.31±0.90 5.05±1.19 4.64±1.69* 48.20±2.77 69.2o±7.26 21.8o±5.36 
lOO 7.26±1.23 5.68±1.54 3.23±1.51 * 44.1o±1.82* 73.6o±5.18 17.0o±3.46 
8Values are given as mean ± S.D. (n = 5). 
bphenol was administered continuously to CD-1 mice in drinking water for four weeks. 
cCell/cu mm. 
dpacked cell volume 
*Significantly (p<0.05) different from control (0 mgIL) values 
Monocytes 
4.60±1.14 
4.80±2.28 
4.60±1.82 
6.20±2.59 
TABLE 31. Effect of Phenol Exposure on the Uptake of [3H]-thymidine by Mice Spleen Cells 
in Culture. 
Dosea 
(mgIL) 
o 
5 
20 
100 
Unstimulated LPS PWM Con A PHA 
Cultures 
5.98±2.18 166.26±53.74 23.59±1O.44 174.33±120.17 146.16 ± 76.44 
5.4o±1.80 173.08±53.92 22.00 ± 6.06 118.94± 91.72 150.66±100.72 
5.62±2.48 148.78±78.82 16.06 ± 8.94 79.00 ± 46.10 106.60 ± 31.34 
3.13±O.80* 89.74±61.58* 8.16 ± 2.99* 95.39 ± 35.96 62.25 ± 42.28* 
~henol was administered continuously to CD-I mice in drinking water for four weeks. 
bValues are given as mean ± S.D. (n=5). 
*Significant (p<0.05) difference from control (0 mg/L) values 
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TABLE 32. Effect of Phenol Exposure on Mixed Lymphocyte Response. 
Dose'" 
(mg/L) Responders Responders + Stimulators 
o 
5 
20 
100 
7.02±1.96a 
4.68±2.29 
3.99±2.89 
4.16±1.01 
22.04±6.71 
24.87±5.26 
10.6S±0.84a 
'" Phenol was administered continuously to CD-I mice in drinking water for four weeks. 
*'" Responder ceUs were the syngeneic splenic cells of CD-I mice and stimuJator cells were the aUogeneic 
Yac-I cells. A ratio of two stimulators to one responder was used, and the stimulator cens were treated 
with mitomycin-C before addition to the cuJture. MLC evaluated by incorporation of [methyl-3H]-
thymidine into day 3 MLC cultures for 6 hours pulsing. Values are given as mean ± S. D. (n=5) 
a Significant (p<0.05) difference from control (0 mg/L) values 
TABLE 33. Effect of Phenol Exposure on Cell-Mediated Cytolytic Response. 
Dose 
(mg/L) 
o 
5 
20 
100 
12.59±1.04 
12.03±2.55 
11.80±1.67 
10.99±1.74 
"values are given as mean ± S.D. (n=5) 
aEffector-target cen ratio 
% Cytoxiclt~ 
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25:1 
13.84±0.75 
12.3o±2.30 
12.20±2.94 
11.23±2.45 
TABLE 34. Effect of Phenol Exposure on Antibody Plaque Fonning Cells (PFC) and 
Antibody Titer (a.-SRBC)a. 
Doseb 
(mg/L) 
o 
5 
20 
100 
PFC/106 Splenic Cells 
1,123±221 
896±135 
795±110* 
616±186* 
&Values are given as mean ± S.D. (n=5) 
PFCrrotal Splenic Cells 
265,947±118,731 
241,678± 39,129 
207,659± 42,184 
130,185± 40,699* 
bphenol was administered continuously to CD-I mice in drinking water for four weeks. 
*Significantly (p<O.05) different from control (0 mg/L) values. 
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a.-SRBC 
Antibody Titer 
0.446±o.086 
0.392±o.152 
0.325±0.042* 
0.263±0.082* 
TABLE 35. Effect of Phenol on Regional Brain Catecbolamines. 
Brain Regions8 
Dosec 
Catecholamineb (mg/L) Hypothalamus Medulla Oblangata Cerebellum 
NE 100 1.272±O.416'" 0.599±O.089 0.287±O.021 
20 1.470±0.403'" 0.628±O.085 0.325±O.033 
5 1.878±O.166 0.681±O.065 0.348±O.066 
0 2.089±0.282 0.767±O.147 0.376±O.066 
VMA 100 0.351±0.117 0.305±O.029 0.330±O.018 
20 0.402±0.058 0.324±O.047 0.384±O.051 
5 0.420±0.065 0.366±O.053 0.382±O.038 
0 0.492±0.067 0.400±O.074 0.377±O.052 
DOPAC 100 0.216±0.081 0.079±O.007 0.047±O.006'" 
20 0.255±0.042 0.094±O.027 0.058±O.008 
5 0.268±0.066 0.085±O.019 0.057±O.007 
0 0.310±0.079 0.081±O.01O 0.057±O.003 
DA 100 0.412±0.158 0.042±O.020 0.020±0.006 
20 0.490±0.154 0.037±O.013 0.024±O.003 
5 0.523±O.I24 0.045±O.015 0.027±O.006 
0 0.569±0.098 0.047±O.006 0.032±O.015 
a J.lg: Brain biogenic amines/g wet brain tissue (mean ± S.D., n=5). Amounts of HV A were not 
detecred. . 
b NE: norepinephrine, VMA: Vanillylmandelic acid, DOPAC: dihydroxypbenylacetic acid" DA: 
dopamine. 
C Doses were administered continuously to CD-I mice in drinking water for 4 weeks. 
'" Significantly (p<O.05) different from control (0 ppm) values. 
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TABLE 36. Effect of Phenol on Regional Brain Catecholarnines. 
Brain Regionsa 
Dosec 
Catecholarnineb (mg/L) Midbrain Corpus Striatum Cortex 
NE 100 0.560±0.025 0.308±O.068 0.405±O.029 
20 0.570±0.094 0.379±O.045 0.370±0.068 
5 0.656±0.058 0.414±O.088 0.473±O.142 
0 0.608±0.093 0.379±O.127 0.424±O.O31 
VMA 100 0.318±0.011 * 0.298±O.030* 0.326±0.022* 
20 0.352±0.042 O.383±O.056 O.329±O.028* 
5 0.379±0.028 0.414±O.034 0.371±O.012 
0 0.402±0.050 0.398±O.O32 0.372±O.O07 
DOPAC 100 0.161±0.024 0.947±O.153* 0.221±O.008 
20 0.174±O.012 1.1 48±O.377 0.239±O.023 
5 0.209±O.058 1. OOO±O.J 53 0.277±O.059 
0 0.219±O.040 1.326±O.203 0.261±O.018 
DA 100 0.275±O.061 6.529±O.950* 1. 173±O.180 
20 0.275±0.046 7.257±O.849* 1.310±0.1l5 
5 0.463±0.205 7.749±1.166* 1.685±O.405 
0 0.320±0.092 9.797±1.887 1.517±O.317 
HVA 100 0.105±0.013 0.774±O.J46 0.176±O.015 
20 0.109±0.009 0.805±O.049 0.173±O.017 
5 0.131±O.038 O.752±O.128 0.201±O.060 
0 0.136±O.022 0.952±O.142 0.214±O.029 
a I1g: Brain biogenic ammes/g wet brain tissue (mean ± S.D., n=5). 
b NE: norepinephrine, VMA: Vanillylmandelic acid, DOPAC: dibydroxyphenylacetic acid, DA: 
dopamine, HV A: homovanillic acid 
C Doses were administered continuously to CD-I mice in drinking water for four weeks. 
* Significant (p<O.05) difference from control (0 mg/L) values. 
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TABLE 37. Effect of Phenol on Regional Brain Indoleamines. 
Brain Regionsa 
Dosec 
Indoleamineb (mg/L) Hypothalamus Medulla Oblangata 
5-Hf 100 0.422±0.119'" 0.531±O.079'" 
20 0.656±0.236'" 0.613±O.105 
5 0.S59±O.114 0.705±O.045 
0 0.967±O.OS7 0.752±O.163 
5-HIAA 100 0.237±O.061'" 0.207±O.031 
20 0.342±O.10S'" 0.247±O.024 
5 0.476±O.OSI 0.258±O.026 
0 0.502±O.097 0.272±O.057 
a Jig: Brain biogenic amines/g wet brain tissue (mean ± S.D., n=5). 
b 5-Hf: 5-hydroxytryptamine (serotonin), 5-HIAA: 5-hydroxyindoleacetic acid. 
C Doses were administered continuously to CD-I mice in drinking water for four weeks. 
'" Significantly (p<0.05) different from control (0 mg/L) values. 
TABLE 38. Effect of Phenol on Regional Brain Indoleamines. 
Brain Regionsa 
Dosec 
Indoleamineb (mg/L) Midbrain Corpus Striatum 
5-Hf 100 0.722±O.059'" 0.457±o.054'" 
20 0.824±0.154 0.627±o.082 
5 0.994±0.OS5 0.735±o.140 
0 0.890±0.037 0.669±o.052 
5-HIAA 100 0.320±0.060 0.257±o.036 
20 0.332±0.069 0.358±o.045 
5 0.411±0.055 0.390±o.097 
0 0.384±o.023 0.344±o.066 
a Jig: Brain biogenic amines/g wet brain tissue (mean ± S.D., 0=5). 
b 5.HT: hydroxytryptamine (serotonin, 5-ffiAA: 5-hydroxyindoleacetic acid. 
C Doses were administered continuously to CD-I mice in drinking water for four weeks 
'" Significantly (p<0.05) different from control (0 mg/L) values. 
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Cerebellum 
OJ 61±O.050 
0.193±O.035 
0.207±O.063 
0.243±O.06S 
0.067±O.021 
0.073±O.013 
0.081±O.021 
0.088±O.026 
Cortex 
0.591±O.050 
0.611±o.052 
0.797±o.186 
0.707±o.039 
0.185±o.020 
0.167±O;015 
0.213±o.067 
0.197±o.()16 
TABLE 39. Body Weigbts of Mice Following 4 Weeks of Exposure to Benzene (200 mg/L) and Toluene 
(400 mg/L). alone or Combined. 
Concentration 
in Water (mg/L) 
Control (0) 
Benrene (200) 
Toluene (400) 
Benrene (200) 
+ 
Toluene (400) 
Day 0 
27.02 ± 0.73 
27.02 ± 0.56 
27.46 ± 0.48 
26.78 ± 0.37 
a Values are given as mean ± S.E. (n=5) 
b Significantly different from untreated controls (p<O.05) 
c Significantly different from toluene treaunent alone (p<0.05) 
Body Weight (g)a 
Day 28 
34.36 ± 0.78 
35.70 ± 1.01 
37.32 ± 1.34 
34.22 ± 0.39 
Gain 
7.34 ± 0.27 
8.68 ± 0.61 
9.86 ± 0.90b 
7.44 ±0.43c 
TABLE 40. Organ Weigbts of Mice Following 4 Weeks of Exposure to Benzene (200 mg/L) and Toluene 
(400 mg/L), alone or Combined. 
Concentration 
in Water (mg/L) 
Control (0) 
Benrene (200) 
Toluene (400) 
Benzene (200) 
+ 
Toluene (400) 
Spleen 
0.31 ± 0.01 
0.28 ± 0.02 
0.29 ± 0.02 
0.28 ± 0.01 
a Values are given as mean ± S.E. (n=5) 
Organ Weights (g/lOOg body weight)a 
Kidney Liver 
1.46 ± 0.05 5.77 ± 0.16 
1.59 ± 0.08 6.28 ± 0.17 
1.54 ± 0.04 5.92 ± 0.17 
1.56 ± 0.05 5.77 ± 0.16 
b Significantly different from untreated controls (p<O.05) 
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Thymus 
0.14 ± 0.01 
0.09 ± 0.02b 
0.11 ± 0.01 
0.11 ± 0.01 
TABLE 41. Effect of Exposure to Benzene (200 mgIL) and Toluene (400 mgIL), Alone or Combined, on Selected Blood Parametersa. 
uukocyte absolute differentia1s (103Jmm3) 
Concentration Etytbrocyte uuk.ocyte 
(mgIL) (l06/mm3) (l03/mm3) Lymphocyte Neutrophil Otherb 
Control (0) 9.73 ± 0.18 6.90 ± 1.08 5.19 ± 1.03 1.17 ± 0.11 0.54± 0.09 
U'I Benzene (200) 7.09 ± 0.2Sc 4.44 ± 0.1~ 2.43 ± 0.1~ 1.60 ± O.11c 0.31 ± 0.04 U'I 
Toluene (400) 9.78 ± 0.23 6.46 ± 0.61 4.67 ± 0.54 1.24 ± 0.05 0.55 ± 0.08 
Benzene (200) 
+ 
Toluene (400) 9.45 ± 0.38d 5.62 ± 0.35 3.60 ± 0.31c,d 1.57 ± 0.16c 0.44 ± 0.07 
a Values are given as mean ± S.E. (n=5). 
b Including monocytes, eosinophils and basophils. 
c Significantly different from untreated controls (p<O.05). 
d Significantly different from benzene treatment alone (p<O.OS). 
f' If fff 
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TABLE 42. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L). Alone or Combined, on Splenic Lymphocyte Proliferative Response to 
Mitogens. . 
Mitogenic responsesa,b 
Concentration Splenocytesa 
(mg/L) (xl 0-7) None LPS PWM 
Control (0) 8.94 ± 1.90 2.02 ± 0.48 79.36 ± 20.14 8.99 ± 0.43 
Benzene (200) 7.90 ± 1.67 1.07 ±0.29 15.01 ± 3.22c 2.53 ± 0.83c 
Toluene (400) 8.61 ± 1.16 1.59 ± 0.52 32.14 ± 5.24 7.72 ± 2.11 
Benzene (200) 
+ 
Toluene (400) 9.29 ± 0.75 3.17 ± 0.S9d,e 12S.41 ± 23.93d,e 10.66 ± 1.31d 
a Values are given as mean ± S.B. (n=5). 
b dpm x 10-3/106 splenic cells: response evaluated by incOlporation of [methyl-3H]-thymidine. 
into day 2 splenocyte cultures for 6 hours pulsing. 
c Significantly different from untreated controls (p.0.05). 
d Significantly different from benzene treatment alone (p.O.OS). 
e Significantly different from toluene treatment alone (p.0.05). 
~ I I ffl 
ConA PHA 
85.45 ± 39.75 103.40 ± 34.64 
13.79 ± 3.48c 14.18 ± 2.15c 
34.87 ± 7.37 43.53 ± 13.S5 
174.51 ± 93.59d 119.S7 ± 2.50d 
TABLE 43. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L). Alone or Combined. 
on Mixed Lymphocyte Response. 
Responder-to-stimulator cell mtioa 
Concentration 
(mg/L) 
Control (0) 
Benzene (200) 
Toluene (400) 
Benzene (200) 
+ 
Toluene (400) 
Responders alone 
1.91 ± 0.36 
0.88 ± 0.22b 
1.09 ± 0.14 
1.99 ± 0.33c,d 
1:1 
6.58 ± 0.88 
4.03 ± 0.53 
3.93 ± 0.60 
7.80 ± 2.46 
2:1 4:1 
17.69 ± 2.70 17.25 ± 2.59 
5.69 ± l.64b 6.50 ± 1.17b 
8.67 ± 2.24b 9.00 ± 0.95b 
22.85 ± 4.62c,d 21.84 ± 3.83c•d 
a Responder cells were the splenocytes of CD-I mice and stimulator cells were the allogeneic Y AC-I 
lymphoma cells (H_2a) of AISn origin. The stimulator cells were treated with mytomycin-C before 
addition to the culture. MLR was evaluated by incorporation (dpm x 10-3) of [methyl-3H]-thymidine 
into day 3 MLR cultures for 6 hours pulsing. Values are given as mean ± S.E. (n=5). 
b Significantly different from untreated controls (p<O.05). 
c Significantly different from benzene treatment alone (p<0.05). 
d Significantly different from toluene treatment alone (p<0.05). 
TABLE 44. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined. on 
Cytotoxic T- Lymphocyte Response. 
% Cytotoxicitya 
Concentration 
(mg/L) 
Control (0) 
Benzene (200) 
Toluene (400) 
Benzene (200) 
+ 
Toluene (400) 
50:1b 
18.74 ± 1.79 
13.29 ± 1.07 
17.33 ± 1.85 
24.11 ± 1.83c,d,e 
a Values are given as mean ± S.E. (n=5). 
25:1 12.5:1 6.25:1 
18.66 ± 1.39 13.23 ± 1.65 7.88 ± 1.66 
14.43 ± 3.78 7.20 ± 0.81c 4.67 ± 0.59 
16.85 ± 2.39 ,9.43 ± 0.71 6.34 ± 0.86 
23.74 ± 1.06d,e 18.11 ± 2.69d,e 9.83 ± 1.02d 
bEffector (day 5 mixed lymphocyte culture lymphocytes)-to-target (51Cr-Iabeled YAC-l ceUs) cell ratio. 
c Significantly different from untreated controls (p<O.05). 
d Significantly different from benzene treatment alone (p<0.05). 
e Significantly different from toluene treatment alone (p<O.05). 
57 
TABLE 45. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined, on 
Antibody Responses to T-Dependent Antigen Sheep Erythrocyte (SRBC)8. 
Total 
Concentration splenocytes PFC/I06 PFC/total spleen cells a. -SRBC 
(mg/L) (x 10-7) splenocytes (x 10-3) antibody titer 
Control (0) 22.01 ± 2.29 1485 ± 66 337.36 ± 44.82 0.78 ± 0.07 
Benzene (200) 17.81 ± 1.18 833 ± 89b 151.41 ± 21.53b 0.47 ± 0.05b 
Toluene (400) 19.02 ± 1.03 1190 ± l09b 229.51 ± 32.30 0.37 ± 0.03 
Bemene (200) 
+ 
Toluene (400) 22.93 ± 1.61 1972 ± 159b•c,d 454.90 ± 42.48c•d 1.24 ± O.lOb•c,d 
8 Mice were sensitized with SRBC 4 days before the end of exposure. Splenic cells were analyzed for 
antibody fonning cells (plaque-fonning cell, PFC) and antibody titer (a. -SRBC) detennined in Sera. 
Values are given as mean ± S.E. (n=5). 
b Significandy different from untreated controls (p<O.05). 
C Significantly different from benzene treatment alone (p<0.05). 
d Significantly different from toluene treatment alone (p<0.05). 
TABLE 46. Body Weights of CD- t Mice Following 4 Weeks of Exposure to Benzene (200 mg/L) and 
Toluene (100 mg/L), Alone or Combined. 
Concentration 
in Water (mg/L) 
Control (0) 
Benzene (200) 
Toluene (100) 
Bemene (200) 
+ 
Toluene (100) 
Day 0 
23.38 ± 0.79 
22.50 ± 0.72 
25.38 ± 0.75 
25.42 ± 0.75 
a Values are given as mean ± S.E. (n=5). 
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Body Weight (g)a 
Day 28 
31.12 ± 1.02 
. 30.44 ± 0.75 
34.72 ± 1.20 
34.14 ± 1.25 
Gain 
7.73 ± 0.41 
7.94 ± 0.54 
9.34 ± 0.56 
8.72 ±0.84 
TABLE 47. Organ Weights of Mice Following 4 Weeks Exposure to Benzene (200 mg/L) and Toluene 
(100 mg/L), Alone or Combined. 
Organ Weights (gll00g body weigbt)a 
Concentration 
in Water (mg/L) 
Control (0) 
Benzene (200) 
Toluene (100) 
Benzene (200) 
+ 
Toluene (100) 
Spleen 
0.29 ± 0.01 
0.24 ± 0.92 
0.29 ± 0.03 
0.26 ± 0.01 
a Values are given as mean ± S.E. (n=5). 
Kidney 
1.79 ± 0.10 
1.73 ± 0.11 
1.74 ± 0.05 
1.73 ± 0.08 
b Significantly different from untreated controls (p<f>.05). 
liver Tbymus 
6.19 ± 0.13 0.17 ± 0.01 
6.29 ± 0.23 0.14 ± O.Olb 
6.02 ± 0.17 0.15 ± 0.01 
6.38 ± 0.17 0.14 ± O.Olb 
TABLE 48. Effect of Exposure to Benzene (200 mg/L) and Toluene (l00 mg/L), Alone or Combined. on 
Splenocyte and Erythrocyte Cellularities. 
Concentration 
(mg/L) 
Control (0) 
Benzene (200) 
Toluene (100) 
Benzene (200) 
+ 
Toiuene (100) 
a Values are given as mean ± S.E. (n=5). 
Splenocytea 
(xl0~7) 
10.80 ± 1.14 
7.8 ± 0.05 
11.38 ± 1.87 
10.74 ± 0.70 
b Significantly different from untreated controls (p<O.05). 
C Significantly different from benzene treatment alone (p<O.05). 
d Significantly different from toluene treatment alone (p<0.05). 
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Erytbrocytea 
(106/mm3) 
9.36 ± 0.18 
6.77 ± 0.35b 
10.42 ± 0.34 . 
0\ 
0 
TABLE 49. Effect of Exposure to Benzene (200 mg/L) and Toluene (100 mg/L). Alone or Combined, 
on Splenic Lympbocyte Proliferative Response to Mitogens. 
Mitogenic responsesB 
Concentration 
(mg/L) None 
Control (0) 2.10 ± 0.71 
Benzene (200) 0.52 ± 0.23 
Toluene (100) 1.49 ± 0.28 
Benzene (200) 
+ 
Toluene (100) 2.05 ± 0.72 
LPS 
55.52 ± 10.24 
4.07 ± 1.10b 
27.13 ± 9.92 
6.02 ± 1.68b 
PWM 
6.72 ± 1.83 
3.31 ± 1.32 
4.49 ± 0.53 
3.79 ± 1.06 
B dpm x 10-3/106 splenic cells: response evaluated by incotporation of [metbyl.3H]-tbymidine into day 2 
splenocyte cultures for 6 bours pulsing. Values are given as mean ± S.B. (n=5). 
b Significandy different from untreated controls (p<O.05). 
C NO, not determined. 
'I flf 
ConA 
72.03 ± 13.33 
10.55 ± 2.82b 
35.72 ± 8.77 
23.55 ± 2.82b 
PHA 
NOC 
NO 
NO 
NO 
TABLE 50. Effect of Exposure to Benzene (200 mg/L) and Toluene (100 mg/L), Alone or Combined, on 
Mixed Lymphocyte Responses. 
Responder-to-stimulator cell mtioR 
Concentration 
(mglL) 
Control (0) 
Benzene (200) 
Toluene (100) 
Benzene (200) 
+ 
Toluene (100) 
Responders Alone 
2.13 ± 0.59 
1.00 ± 0.13 
1.43 ± 0.63 
1.54 ± 0.37 
1:1 
7.98 ± 1.84 
7.05 ± 1.49 
6.29 ± 0.64 
7.36 ± 1.36 
2:1 4:1 
18.73 ± 2.16 16.47 ± 0.89 
8.62 ± 1.60b 5.76 ± 0.69b 
14.25 ± 1.51 11.29 ± 3.37 
8.54 ± 1.16b,c 8.16 ± 1.60b 
R Responder cells were the splenocytes of CD-I mice and stimulator cells were the allogeneic Y AC-l 
lymphoma cells (H_2R) of AlSn origin. The stimulator cells were treated with mytomycin-C before 
addition to the culture. MLR was evaluated by incorporation (dpm x 10-3) of [methyl-3H]-thymidine 
into day 3 MLR cultures for 6 hours pulsing. Values are given as mean ± S.E. (n=5). 
b Significantly different from untreated controls (p<O.05). 
c Significantly different from toluene treatment alone (p<0.05). 
TABLE 51. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined, on 
Bmin Biogenic Amines and Their Major Metabolites in Hypothalamus. . 
Concentrations (J.lg/g Wet Tissue)R 
Doses 
(mgIL) NE DA 5-RT DOPAC HVA 5-HlAA 
Control (0) 1.87±O.14 0.49±0.08 0.37±O.05 0.22±0.04 0.16±O.02 0.32±0.07 
Benzene (200) 2.77±O.26b 0.74±O.07b 0.71±O.04b 0.37±O.07 0.26±O.03b 0.69±O.04b 
Toluene (400) 2.90±0.18b 0.62±O.O7 0.76±O.07b 0.35±O.05 0.24±O.03 0.68±0.05b 
Benzene (200) 
+ 
Toluene (400) 3. 19±O.30b 0.82±O.06b 0.71±O.08b 0.42±0.05 0.29±O.03b 0.76±0.06b 
R Values are given as mean ± S.E. (n=5). 
b Significantly different from untreated controls (p<0.05). 
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TABLE 53. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined, on Brain Biogenic Amines and Their 
Major Metabolites in Corpus Striatum and Midbrain of CD-I Mice. 
Biogenic Amines Concentrations (Ilg/g Wet Tissue)a 
Brain Doses 
Region (mg/L) NE DA S-HI' VMA DOPAC HVA S-HIAA 
Control (0) 0.3I±O.06 7.27±O.SS 0.36±O.OS 0.12±O.02 1.21±0.07 0.93±0.07 0.SS±O.07 
Corpus Bell2"ene (200) 0.43±O.06 10.10±0.62b O.64±O.OSb 0.16±0.01 1.43±0.11 1.28±O.09b 0.67±O.06 
Striatum 
Toluene (400) 0.44±O.07 9.01±O.48 0.6I±O.09b O.13±O.OI 1.46±O.13 1.09±0.OS 0.58±O.OS 
Bell2"eDe (200) 
+ 
0\ Toluene (400) 0.4S±O.03 9.2S±O.S~ 0.60±0.03b O.l1±O.OI 1.92±0.16b,c,d 1.27±O.OSb 0.72±O.04 
1...:1 
Control (0) 0.66±O.03 0.27±O.OS 0.68±0.03 0.09±0.02 0.21±0.03 0.13±0.01 O.5S±O.01 
Bell2"ene (200) 0.84±O.03b 0.39±O.04 1. I O±O. 02b 0.08±0.00 0.18±O.01 0.19±O.0Ib 0.71±O.04b 
Midbrain 
Toluene (400) 0.73±O.02 0.44±O.18 0.9S±O.04b 0.10±0.01 0.22±O.04 0.18±O.02 0.63±O.03 
Bell2"ene (200) 
+ 
Toluene (400) 0.67±O.OSc 0.38±0.04 O.89±O.09 O.13±O.OI b,c 0.18±O.01 0.16±0.01 0.71±O.03b 
a Values are given as mean ± S.E. (n=5). 
b Significantly different from coJ;ltrois (p<O.05). 
C Significantly different fum benzene treabnent alone (p<O.05). 
d Significantly different from toluene treatment alone (p<O.05). 
TABLE 54. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined, on 
Brain Biogeoic Amines and Their Major Metabolites in Cerebellum of CD-I Mice. 
Concentrations (Ilg/g Wet Tissue)a 
Doses 
(mg/L) 
Control (0) 
Benzene (200) 
Toluene (400) 
Bem.ene (200) 
+ 
Toluene (400) 
NE 
0.24 ± 0.02 
0.30 ± 0.01 
0.31 ± 0.02 
0.34 ± O.03b 
a Values are given as mean ± S.E. (n=5). 
5-HT 
0.12 ± 0.02 
0.19 ± 0.01 
0.13 ± 0.02 
0.16 ± 0.01 
b Significantly different from controls (p<O.05). 
a Values are given as mean ± S.E. (n=5). 
b Significantly different from controls (p<0.05). 
C Significantly different from benzene treatment alone (p<O.05). 
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VMA 
0.12 ± 0.02 
0.10 ± 0.02 
0.14 ± 0.05 
0.15 ± 0.03 
5-HIAA 
0.17 ± 0.01 
0.17 ± 0.00 
0.16 ± 0.02 
0.18 ± 0.01 
, '! II! 
TABLE 57. Effect of Exposure to Benzene (200 mgIL) and Toluene (100 mgIL), Alone or Combined, on Brain Biogenic Amines and Their Major Metabolites in 
Corpus Striatum and Midbrain of CD-I Mice. 
Biogenic Amines Concentrations (Ilg!g Wet Ttssue)a 
Braio Doses 
Region (mgIL) NE DA 5-Hr OOPAC HVA 5-FHAA 
Control (0) 0.33±O.04b 7.14±O.63 0.64±0.04 0.S2±O.OS O.S7±O.11 O.41±O.04 
Corpus BeJl7ale (200) O.43±O.04 S.6S±O.21 0.67±0.O5 1.07±O.05 1.21±O.04b O.49±O.O6 
Striatum 
Toluene (100) 0.54±O.04b S.02±O.46 O.67±0.O6 1.16±O.06b 1.2S±O.04b O.54±O.05 
Benzene (200) 
+ 
<.:1'1 Toluene (100) O.54±0.05b 9.23±O.36b <.:1'1 O.77±O.OS 1.25±O.lOb 1.51±0.07b,c.d O.56±O.OS 
Control (0) O.55±O.O5 O.19±O.OI O.SO±O.09 O.13±O.OI O.16±O.O2 O.49±O.O2 
Benmne (200) O.74±O.02b O.33±O.OS 1. 13±O.04b O.13±O.OI O.l9±O.Ol O.66±O.04b 
Midbrain 
Toluene (100) O.66±0.04 O.22±0.O2 O.96±O.07 O.ll±O.02 O.15±O.Ol 0.67±O.OSb 
Benmne (200) 
+ 
Toluene (100) O.65±0.04 0.34±O.07 O.97±O.07 O.17±O.03 0.22±0.03 0.67±O.OSb 
a Values are given as mean ± S.E. (n=5). 
b Significantly different from controls (p<O.05). 
c Significantly different from benzene treatment alone (p<O.05). 
d Significantly different from toluene treatment alone (p<O.05). 
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TABLE 58. Effect of Exposure to Benzene (200 mg/L) and Toluene (100 mg/L), Alone or Combined, on 
Brain Biogenic Amines and Their Major Metabolites in Cerebellum of CD-I Mice. 
Doses 
(mg/L) 
Control (0) 
Benzene (200) 
Toluene (100) 
Benzene (200) 
+ 
Toluene (100) 
NE 
0.24 ± 0.03 
0.26 ± 0.01 
0.28 ± 0.03 
0.23 ± 0.01 
Concentrations (J.lg/g Wet Tissue)a 
5-HT 5-lflAA 
0.14 ± 0.03 0.14 ± 0.02 
0.15 ± 0.02 0.14 ± 0.01 
0.18 ± 0.02 0.16 ± 0.01 
0.14 ± 0.01 0.15 ± 0.02 
a Values are given as mean ± S.E. (n=5). Amounts of other amines or their metabolites were not 
detected. 
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